p08126 UIP Final 2009_107.indd - AIM Group

XVI 

WORLD MEETING 

OF THE 

UNION 

INTERNATIONALE 

DE PHLEBOLOGIE 

Under the High Patronage 

of His Serene Highness 

Prince Albert II of Monaco 

AUGUST 31 st 

SEPTEMBER 4 th , 2009 

GRIMALDI FORUM 

PRINCIPALITY OF MONACO 

Final Programme www.uip2009.eu

IMPORTANT ADDRESSES 

ORGANIZING AND SCIENTIFIC SECRETARIAT 

Publi Créations - Partner of AIM 

E-mail: uip2009@publicreations.com 

www.uip2009.eu 

CONGRESS VENUE 

Grimaldi Forum 

74, Bd d’Italie - 98000 Monte-Carlo - Monaco 

Ph.: +377 97 97 3555 - Fax: +377 97 97 3550 

Avenue Princesse Grace - 98000 Monte-Carlo - Monaco 

Ph.: +377 99 99 2000 - Fax: +377 99 99 2001 

E-mail: gf@grimaldiforum.mc 

www.grimaldiforum.mc

T A B L E O F C O N T E N T S 

INTERNATIONAL SCIENTIFIC ADVISORY BOARD 4 

COMMITTEES 5 

WELCOME TO MONACO 6 

ACKNOWLEDGMENTS 7 

PROGRAMME AT A GLANCE 8 

SCIENTIFIC PROGRAMME 10 

LIST OF ACCEPTED POSTERS 40 

LIST OF ACCEPTED VIDEOS 41 

SCIENTIFIC INFORMATION 42 

EXHIBITION PLAN 44 

LIST OF EXHIBITORS 45 

GENERAL INFORMATION 46 

MONACO CITY MAP 50 

3

4 

INTERNATIONAL SCIENTIFIC ADVISORY BOARD 

G. AGUS (Italy) 

Y. AKSALI (Turkey) 

C. ALLEGRA (Italy) 

E. ALTMANN-CANESTRI (Argentina) 

M. ANDRADE (Brasil) 

F.A. ALLAERT (France) 

P.L. ANTIGNANI (Italy) 

J. BARRETT (New Zealand) 

J.P. BENIGNI (France) 

J. BERGAN (USA) 

I. BIHARI (Hungary) 

W. BLÄTTLER (Switzerland) 

V. BLAZEK (Germany) 

E. BLIN (France) 

F. BOCCARDO (Italy) 

P. BOIVIN (France) 

S. BOUSETTA (France) 

A. BRADBURY (United Kingdom) 

L.BRAJESH (United Kingdom) 

M. BRAVO-MARTINEZ (Chile) 

E. BRIZZIO (Argentina) 

K. BURNAND (United Kingdom) 

A. CAGGIATI (Italy) 

C. CAMPISI (Italy) 

M. CAPPELLI (Italy) 

P. CARPENTIER (France) 

M. CAUZABON (France) 

A. CAVEZZI (Italy) 

J.M. CHARDONNEAU (France) 

F. CHLEIR (France) 

D. CHRISTIAN (France) 

R. COHEN (Israel) 

P. COLERIDGE SMITH (United Kingdom) 

A. COMEROTA (USA) 

P. CONRAD (Australia) 

A. CORNU-THÉNARD (France) 

D. CRETON (France) 

M. DALSING (USA) 

D. DAMSTRA (The Netherlands) 

A. DAVIES (United Kingdom) 

E. DE BOER (The Netherlands) 

M. DE MAESENER (Belgium) 

J.J. DITMAR (Brasil) 

J.U. DOMINGUEZ (Colombia) 

I. DRESCIK (Croatia) 

J.L. DUPUIS (Canada) 

B. EKLÖF (Sweden) 

E. A. ENRICI (Argentina) 

M.E. ENRIQUEZ VEGA (Mexico) 

M. FLOUR (The Netherlands) 

H. FRONEK (USA) 

A. FRULLINI (Italy) 

G. GALLENKEMPER (Germany) 

V. GASBARRO (Italy) 

A. GASPARIS (USA) 

G. GENOVESE (Italy) 

H. GERLACH (Germany) 

A. GIANNOUKAS (Greece) 

J.L. GILLET (France) 

P. GLOVICZKI (USA) 

J.P. GOBIN (France) 

M. GOLDMAN (USA) 

P. GUALTIERO (Italy) 

C.H. DESNOS (France) 

K. HARTMANN (Germany) 

H.J. HERMANNS (Germany) 

S. HOSHINO (Japan) 

E. A. HUSSEIN (Egypt) 

E. INTRIAGO-GILER (Ecuador) 

T. IWAI (Japan) 

G. JANTET (France) 

C. JEANNERET (Switzerland) 

M. JÜNGER (Germany) 

L. KABNICK (USA) 

B. KAHLE (Germany) 

D.I KIM (Korea) 

R. KISTNER (USA) 

H. KLUESS (Germany) 

L. KOLLAR (Hungary) 

J.P. KUIPER (The Netherlands) 

S. KÜPFER (Switzerland) 

M. KURTOGLU (Turkey) 

N. LABROPOULOS (USA) 

J. LAREDO (USA) 

B.B. LEE (USA) 

M.L. VILLARDEBO (France) 

J. LOHR (USA) 

D. LOOSE (Germany) 

M. LUGLI (Italy) 

F. LURIE (USA) 

V. M. CANATA (Paraguay) 

O. MALETI (Italy) 

M. MALOUF (Australia) 

S. MANCINI (Italy) 

M. MARSHALL (Germany) 

R. MATTASSI (Italy) 

J. MAURIELLO (USA) 

M. MEISSNER (USA) 

S. MICHELINI (Italy) 

R. J. MIN (USA) 

N. MORRISON (USA) 

P. MORTIMER (United Kingdom) 

A. MUMME (Germany) 

K. MYERS (Australia) 

P. NEGLEN (USA) 

O. NELZÉN (Sweden) 

D. NEUHARDT (USA) 

H.M. NEUMANN (The Netherlands) 

A. NICOLAIDES (Cyprus) 

J. NIGRO (Argentina) 

T. NOPPENEY (Germany) 

F. PADBERG (USA) 

F. PANNIER (Germany) 

K. PARSI (Australia) 

H. PARTSCH (Austria) 

M. PATEL (India) 

M. PERRIN (France) 

O. PICHOT (France) 

N. PILLER (Australia) 

P. PITTALUGA (France) 

I. PIZARRO (Chile) 

P. POLTERAUER (Austria) 

P. PORTALES (Chile) 

T. PROEBSTLE (Germany) 

E. RABE (Germany) 

S. RAJU (USA) 

D. RAMAKRISHNA (India) 

A.A.RAMELET (Switzerland) 

P. RAYMOND-MARTIMBEAU (Canada) 

S. RICCI (Italy) 

L. RILANTONIO (Indonesia) 

A. ROMANO (Argentina) 

N. ROSLI (Argentina) 

P. ROTH (France) 

W. SALMHOFER (Austria) 

M. SCHADECK (France) 

A. SCHAPIRA (Argentina) 

L. SCHIMMELPFENNIG (Germany) 

J.C. SCHOEVARDTS (Belgium) 

S. SCHULLER-PETROVIC (Austria) 

C. SCHWAHN-SCHREIBER (Germany) 

A. SCUDERI (Brasil) 

J. SEYCEK (Czech Republic) 

M. SICA (France) 

R. SIMKIN (Argentina) 

A. SOMMER (The Netherlands) 

I. STAELENS (Belgium) 

H. STEGE (Germany) 

D. STENGER (Germany) 

J. STREJCEK (Czech Republic) 

M. STÜCKER (Germany) 

K. SVATOPLUK (Czech Republic) 

J.F. UHL (France) 

J. VAN DER STRICHT (Belgium) 

A. VAN RIJ (New Zealand) 

R. VARNAGY (Venezuela) 

F. VEGA RASGADO (Mexico) 

L. VILLAVICENCIO (USA) 

F. VIN (France) 

T. WAKEFIELD (USA) 

P. WALLOIS (France) 

V. WIENERT (Germany) 

R. WINTERBORN (United Kingdom) 

C. WITTENS (The Netherlands) 

T. YAMAKI (Japan) 

P. ZAMBONI (Italy) 

S. ZIMMET (USA)

ORGANIZING COMMITTEE 

Chairman 

Dr Jean-Jérôme GUEX (Nice, FRANCE) 

Co-chairman 

Dr Horst GERLACH (Mannheim, GERMANY) 

C O M M I T T E E S 

UIP Board 

President of Honour Founder 

Raymond TOURNAY ✝ 

Presidents of Honour 

Hendrick Roelof VAN DER MOLEN ✝ - Jean VAN DER STRICHT - André DAVY 

Georges JANTET - Hugo PARTSCH 

President 

Eberhard RABE 

Past President 

Claudio ALLEGRA 

Vice Presidents 

John J. BERGAN - Byung Boong LEE - Mark MALOUF 

Angelo SCUDERI - Jaroslav STREJCEK 

General Secretary 

Ivan STAELENS 

Assistant General Secretary 

André CORNU THENARD 

Treasurer 

Jean-Jérôme GUEX 

Founding Members 

M. AUDIER ✝ - G. BASSI ✝ - M. COMEL ✝ - C. HURIEZ ✝ - J. MARMASSE ✝ 

R. TOURNAY ✝ - H.R. VAN DER MOLEN ✝ - P. WALLOIS 

UIP Committee of Honour 

P. CONRAD - A. DAVY - S. HOSHINO 

G. JANTET - J.P. KUIPER - H. PARTSCH 

SCIENTIFIC COMMITTEE 

Chairman 

Prof. Eberhard RABE (Bonn, GERMANY) 

Co-chairman 

Dr Michel SCHADECK (Paris, FRANCE) 

M. PERRIN - A. A. RAMELET - P. RAYMOND-MARTIMBEAU 

N. ROSLI - J. VAN DER STRICHT - S. UMANSKY - P. WALLOIS 

5

6 

W E L C O M E T O M O N A C O 

Dear Participants, 

Dear Colleagues and Friends, 

It gives me great pleasure to welcome you to the Principality of Monaco and I am 

proud to host the 16 th World Meeting of the “Union Internationale de Phlébologie”. 

I sincerely hope that you will have the opportunity to discover or rediscover Monaco 

during your short stay with us. 

The Monaco Convention Bureau’s team, together with the travel and tourism 

industry partners of the Principality are at your full disposal. 

Please do not hesitate to challenge us for any question or request you may have. 

I do wish you a highly productive Congress and a very enjoyable stay with us. 

Kindest regards, 

Michel BOUQUIER 

President 

Monaco Government Tourist 

and Convention Authority 

On behalf of the French and German societies of 

Phlebology, we welcome you to the XVI World Meeting 

of the Union Internationale de Phlébologie. 

This congress celebrates the 50 th anniversary of the 

Union founded in Meyrargues , not far from Monaco. 

For the first time, a meeting of the UIP is organized by 

two countries in the capital of the third one. These facts 

explain the name and the logo of the meeting. 

The phlebological community can be proud of the 

progress obtained in the last fifteen years. Care given to 

venous patients is more and more efficient, quick, painless and durable. The incidence of most severe 

forms of chronic venous disorders decreases because we have treated patients earlier and better. The 

new electronic media have accelerated diffusion of information and international cooperation. And 

finally, Evidence Based Phlebology exits. 

This meeting will be the occasion to summarize the latest progress, to update our knowledge and to devise 

new research, it is the place where you will meet with colleagues and make new friends from overseas. 

We are certain that you will enjoy the program, the venue, the country and all the opportunities that 

we have planned for you. 

However, take some time to visit this lovely country and discover its mediterranean magic. 

Dr. Jean-Jerôme GUEX 

Chairman of the Organizing Committee 

Prof. Eberhard RABE 

Chairman of the Scientific Committee

A C K N O W L E D G M E N T S 

The Organizing and Scientific Committees express their gratitude to the following Companies 

for their generous contribution to the success of the congress: 

PLATINUM SPONSORS 

Bauerfeind AG is one of the leading manufacturers 

of medical aids such as compression stockings, 

supports, orthoses, orthopedic insoles and 

prosthetic components. The high-quality products 

with the respected „Made in Germany“ label 

make an important contribution to maintaining 

and restoring health. 

Servier is a private, independent French 

pharmaceutical company, led by the founder Dr 

Jacques Servier. Servier is involved in research 

and development, manufacture and marketing 

of ethical pharmaceuticals, and is present in 

140 countries. Discovery of major innovative 

treatments have been achieved, among them 

Protelos, Procoralan, Valdoxan and Daflon 

500mg (Micronized Purified Flavonoid Fraction): 

the most prescribed venoactive drug in the world 

acting at the core of venous inflammation. 

GOLD SPONSORS 

SILVER SPONSORS 

Pierre Fabre is a French private group developing, manufacturing and 

distributing ethical and pharmaceutical, OTC and dermo-cosmetic 

products. Pierre Fabre achieved a turnover of 1.75 billion euros in 2008 

and employs 9,800 persons in over 40 countries. 1,400 employees 

are in the field of research, to which Pierre Fabre dedicates 25% of 

its pharmaceutical turnover in five major therapeutic axes: oncology, 

cardiovascular, central nervous system, urology and dermatology. 

BRONZE SPONSORS 

Kreussler Pharma, founded in 1912, 

is the inventor and manufacturer of 

Aethoxysklerol®, the leading sclerosing 

agent for varicose vein therapy with 

252,500,000 millilitres used worldwide 

since 1987, allowing to perform more than 100,000,000 efficacious 

and safe sclerotherapy treatments. 

Medical devices from medi (with a focus on 

compression therapy) ensure successful 

treatment in over 90 countries all over the world. 

medi products “made in Germany” can be found 

in specialist medical retailers, in hospitals and 

clinics as well as in doctors’ and therapists’ 

practices. 

150 years of expertise and presence on the market. The family business takes its roots in Winterthur - Switzerland, 

in the heart of Europe, in 1864. It is now run by the fifth generation which continues to perpetuate the SIGVARIS 

tradition and know-how based on a solid and visionary strategy. Over 50 years ago, the company took a decisive turn 

to focus on a core activity: producing medical compression stockings as a solution for treatment of venous disease. 

Today, over 60 millions of legs have worn SIGVARIS medical compression stockings worldwide. 1200 employees 

spread over eight companies of the SIGVARIS Group are committed to providing «Life for Legs» to people suffering 

from venous disease, and are contributing each day to making SIGVARIS the world leader and expert number one 

in medical compression stockings 

BSN medical with it’s well-known brands – RADIANTE® and JOBST® – is 

a worldwide leading company in the compression therapy market and a 

solutions provider for wound care and orthopaedics (fracture management 

and physiotherapy). 

STD Pharmaceutical Products Ltd is a family run business 

supporting sclerotherapists. We provide a sclerosant, 

Fibro-Vein, plus needles, syringes & bandages. We 

also promote iontophoresis, an effective treatment for 

hyperhidrosis of the hands, feet & axillae. 

VENOSAN® Medical Stockings from 

the SALZMANN GROUP - ST.GALLEN - 

SWITZERLAND - Innovation in compression 

therapy, bringing an improvement to quality of 

life for patients in more than 60 countries around 

the world. 

Leader in compression therapy since 1926, Gloria-Med-Group 

means highest quality in medical compression stockings, support 

socks/pantyhose, anti-embolism stockings and elastic bandages. 

Manufactured to strict specifications, stockings are offered in various 

fabrics, compression classes, styles and colours. Gloria-Med-Group 

range includes Cosmeceutics, Nutraceutics, Sclerotherapy products, 

Diagnostics and Vascular instruments. Our long experience and constant medical research in the 

field of veno-lymphatic disorders is guarantee for a better patient compliance. 

7

8 

P R O G R A M M E A T A G L A N C E 

MONDAY, AUGUST 31st SESSION CODE 

Talk to the experts - Lasers and veins AP1.1 

07.30 - 08.45 Talk to the experts - Diagnostic approach to venous malformations BO1.1 

Talk to the experts - Sclerotherapy treatment of reticular and telangiectatic veins GE1.1 

09.00 - 10.00 UIP News, Awards PP1.2 

10.00 - 11.00 Venous Malformations and Lymphoedema PP1.3 

11.30 - 12.20 Guest lecture - Phlebology in the last 50 years: Varicose Veins and Venous Ulcers PP1.4 

12.20 - 13.00 Venous symptoms and clinical assessment PP1.5 

13.00 - 14.00 STD Pharmaceutical Symposium - Foam sclerotherapy in 2009 (Lunch session) CB1.6 

13.00 - 15.00 Council Meeting (by invitation: presidents of members of societies and board members) 

14.00 - 15.00 Presentation of posters by authors: posters DIA1 to DIA16 CB1.6 

Endovenous Procedures 1 - Diagnosis and Anesthesia PP1.7 

14.00 - 16.00 Sclerotherapy 1 - Basic consideration AP1.7 

Compression Treatment 1- Pressure measurements GE1.7 

14.30 - 15.15 Pierre Fabre Symposium - 1st part. CB1.8 

Venous ulcer: the fi nal stage in chronic venous disease - Managing it in 2009 

CB1.8 

15.30 - 16.15 Pierre Fabre Symposium - 2nd I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I part. Compression therapy: new device I 

I I CB1.9 

15.30 - 17.30 I Session of the Latin American Chapter I 

I I SC1.9 

16.30 - 17.15 I Max Ratschow Medal Session (Collegium Internationalis Angiologiae) I 

I I AP1.10 

I Endovenous Procedures 2 - Comparative Studies I 

I I PP1.11 

I 

16.30 - 18.30 

ICC Symposium: New methods to evaluate compression therapy I CB1.11 

I I 

I Session of the Asian and Australasian Chapter I BO1.11 

I I 

I Venous Anatomy and Epidemiology I GE1.11 

17.15 - 18.30 

I 

Venous Malformation 

I 

I I 

AP1.12 

TUESDAY, SEPTEMBER 1st I SESSION I 

I I CODE 

I 

Talk to the experts - The Neovalve in PTS - tips and tricks 

I 

I I AP2.1 

07.30 - 08.45 I Talk to the experts - My technique in compression treatment - bandages or stockings I 

I I BO2.1 

I Talk to the experts - Esthetic treatments and phlebology practice I 

I I 

GE2.1 

09.00 - 11.00 I Thromboembolic Disease I PP2.2 

I I 

11.30 - 12.00 I Guest lecture - Why do varicose veins develop? I PP2.3 

12.00 - 13.00 

I 

UIP Consensus Varicose Veins 

I 

I I PP2.4 

I Session of the German Society of Phlebology (Board meeting) - (by invitation only) I AP2.5 

13.00 - 14.00 I I 

I VNUS Workshop I 

I I 

BO2.5 

14.00 - 15.00 I Presentation of posters by authors: posters DIA17 to DIA31 I CB1.6 

I I 

I Servier Symposium - Management of chronic venous disease: I CB2.6 

14.00 - 15.30 I I CB2.6 

I therapeutic recommendations 

I 

I I 

I Sclerotherapy 2 - Miscellaneous I PP2.6 

I I 

14.00 - 16.00 I Endovenous Procedures 3 - Prospective Studies I AP2.6 

I 

Session of the German Society of Phlebology: Varicose Veins and Venous Ulcers 

I 

I I BO2.6 

I Short free paper Session I I 

I I GE2.6 

15.30 - 16.00 I Lecture: Microcirculation in Phlebology I 

I I CB2.7 

I Sclerotherapy 3 - Safety Aspects I 

I I 

PP2.8 

I Venous Pathophysiology I CB2.8 

I I 

16.30 - 18.30 I Endovenous Procedures 4 - Wavelength and new Fibres I AP2.8 

I 

Session of the German Society of Phlebology: Endovenous treatment: Obesity and CVI 

I 

I I BO2.8 

I Venous Diagnosis 1 I 

I I GE2.8 

WEDNESDAY, SEPTEMBER 2nd SESSION CODE 

Talk to the experts - 3D-Imaging of the venous system AP3.1 

07.30 - 08.45 Talk to the experts - Closure fast - indications and how to do it BO3.1 

Talk to the experts - Duplex of the deep veins - tips and tricks GE3.1 

09.00 - 09.45 Special issue in Phlebology PP3.2 

09.45 - 11.00 Chronic Cerebro - Spinal Venous Insuffi ciency (CCSVI): Diagnosis and treatment PP3.3 

11.30 - 12.00 Guest lecture - Asymptomatic deep venous thrombosis PP3.4 

12.00 - 13.00 UIP Consensus - Curriculum in Phlebology PP3.5 

13.00 - 14.00 Session of the German Society of Phlebology - Bauerfeind award - Hartmann price AP3.6 

13.00 - 15.00 Council Meeting (by invitation: presidents of members of societies and board members) GE3.1 

14.00 - 15.00 Presentation of posters by authors: posters DIA32 to DIA46 

Medi Symposium - Compression therapy after surgery and endovenous procedures PP3.7 

Endovenous procedures 5 - RFA CB3.7 

14.00 - 16.00 Sclerotherapy 4 - Teleangiectasias and Reticular Veins AP3.7 

Session of the French Society of Phlebology 

1st BO3.7 

part: Cooperative studies of the French Society of Phlebology 

Lymphoedema / Pelvic Veins GE3.7 

Endovenous Procedures 6 - Combined Treatment PP3.8 

Venous Surgery 1 CB3.8 

Bauerfeind Symposium - The venous ulcer - patient between compression and intervention AP3.8 

16.30 - 18.30 

Session of the French Society of Phlebology - 2nd I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I I 

I part: Treatment of chronic venous disorders: I BO3.8 

I 

French and Russian convergences 

I 

I I BO3.8 

I Venous ulcer Treatment - Grafts I 

I I GE3.8

LEGEND 

EXAMPLE: PP1.1-1 

PP 

ROOM 

P R O G R A M M E A T A G L A N C E 

THURSDAY, SEPTEMBER 3rd I I 

I I 

I SESSION I CODE 

I I 

I Talk to the experts - Interaction of Detergent Sclerosants with the coagulation system: I 

I I AP4.1 

I an update I 

I I 

AP4.1 

07.30 - 08.45 I Talk to the experts - DVT - How to treat in daily practice? I BO4.1 

I I 

I Talk to the experts - Radiofrequency and Laser Venous Ablation: Results and Complications I GE4.1 

09.00 - 11.00 

I 

Varicose Veins 

I 

I I PP4.2 

11.30 - 12.00 I Guest lecture - Chronic venous Insuffi ciency - Think obstruction I 

I I PP4.3 

12.00 - 13.00 I UIP Consensus Venous Oedema & Skin changes I 

I I 

PP4.4 

13.00 - 14.00 I Servier Vein Consult Project I BO4.5 

I I 

13.00 - 15.00 I Session of the German Society of Phlebology - General Assembly I AU4.5 

14.00 - 15.00 

I 

Presentation of posters by authors: posters DIA47 to DIA61 

I 

I I CB1.6 

I Sclerotherapy 5 - Saphenous Veins I 

I I PP4.6 

I Joint Symposium on Phlebolymphedema 

I 

I I CB4.6 

14.00 - 16.00 

I International Union of Phlebology & European Society of Lymphology 

I 

I I 

I Endovenous Procedures 7 - Complications I AP4.6 

I 

Session of the American Venous Forum 

I 

I I BO4.6 

I Short Free Paper Session II I 

I I GE4.6 

I Venous Diagnosis 2 I 

I I 

PP4.7 

I BSN JOBST Symposium - Patient compliance in compression therapy - Does it really matter? I CB4.7 

I I 

16.30 - 18.30 I Thromboembolic Diseases 1 I AP4.7 

I 

Session of the American College of Phlebology 

I 

I I BO4.7 

I Short Free Paper Session III I 

I I 

GE4.7 

FRIDAY, SEPTEMBER 4th I SESSION I 

I I CODE 

I 

Talk to the experts - Foam Sclerotherapy and phlebectomy - what are the best strategies? 

I 

I I AP5.1 

07.30 - 08.45 I Talk to the experts - Ilio-femoral obstruction - how to treat the disease? I 

I I BO5.1 

I Talk to the experts - US Guided foam sclerotherapy: references and practical applications I 

I I 

GE5.1 

09.00 - 11.00 I Deep Venous Insuffi ciency I PP5.2 

I I 

11.30 - 12.00 I Guest lecture - Embryology of the venous network I PP5.3 

12.00 - 13.00 

I 

UIP Consensus Venous Malformation & Lymphoedema 

I 

I I PP5.4 

I Endovenous Procedures 8 - Treatment / Sclerotherapy 6 - Safety I 

I I PP5.6 

I Sigvaris Symposium - Medical compression Stockings (MCS) for venous disorders and I 

I I 

CB5.6 

CB5.6 

I diseases - original studies presented by the authors 

I 

I I 

14.00 - 16.00 I Varicose Veins - Miscellaneous I AP5.6 

I 

Session of the European Venous Forum - Workshop on updating international 

I 

I I 

I BO5.6 

guidelines on the prevention of venous thromboembolism 

I 

I I 

I Venous Surgery 2 I 

I I 

GE5.6 

I Venous Ulcer Treatment II I PP5.7 

I I 

I Short Free Paper Session IV I AP5.7 

16.30 - 18.30 

I 

Session of the Italian College of Phlebology - Endovascular treatment of Varicose Veins 

I 

I I BO5.7 

I Thromboembolic disease II I 

I I GE5.7 

1 

DAY 

. 

1 

SESSION 

S C I E N T I F I C P R O G R A M M E 

Sunday, August 30 th 

09.00-18.30 UIP Pre-Conference (by invitation only) 

Prince Pierre 

18.30-19.30 Opening Ceremony 

Exhibition hall Diaghilev 

19.30-21.00 Welcome Reception 

- 

1 

PRESENTATION 

Morning Afternoon Sponsored Symposia 

ROOMS DAYS 

PP = PRINCE PIERRE 1 = MONDAY 

AP = APOLLINAIRE 2 = TUESDAY 

GE = GENEVOIX 3 = WEDNESDAY 

BO = BOSIO 4 = THURSDAY 

CB = CAMILLE BLANC 

SC = SCOTTO 

5 = FRIDAY 

9

10 


Monday, August 31 st 

07.30-08.45 

Apollinaire Talk to the experts (AP1.1) 

R. Weiss: Lasers and veins 

A.A. Ramelet: discussant moderator 

Bosio Talk to the experts (BO1.1) 

B.B. Lee: Diagnostic approach to venous malformations 

M. Meissner: discussant moderator 

Genevoix Talk to the experts (GE1.1) 

J.J. Guex: Sclerotherapy treatment of reticular and telangiectatic veins 

S. Zimmet: discussant moderator 

08.45-09.00 Coffee break in Exhibition hall 

09.00-10.00 

Prince Pierre UIP News, Awards (PP1.2) 

Chairpersons: E. Rabe, J.J. Guex 

PP1.2-1 E. Rabe, J.J. Guex: Welcome, News from UIP 

PP1.2-2 Report of last winners: 

C. Rosi: UIP-Servier Research Fellowship 

R. Ceulen: Bauerfeind Award 

PP1.2-3 New awards: 

- Servier Research Fellowship 

- Bauerfeind Award 

- 1 st Kreussler Young Scientists’ Sclerotherapy Award 

PP1.2-4 N. Morrison, A. Cavezzi: Charity activities in phlebology 

Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre) 

10.00-11.00 

Prince Pierre Venous Malformations and Lymphoedema (PP1.3) 

Chairperson: B.B. Lee 

Moderator: N. Piller 

PP1.3-1 B.B. Lee: Venous Malformation: it is not an AV-Malformation 

PP1.3-2 A. Caggiati: New nomenclature of embryological veins 

PP1.3-3 R.J. Damstra, H. Partsch: Comparative, prospective study between volume 

and low and high interface pressure under short stretch compression bandages 

in the treatment of breast cancer lymphedema 



11.30-12.20 

Prince Pierre Guest lecture (PP1.4) 

Chairperson: J. Bergan 

K. Burnand, C. Jeanneret: Phlebology in the last 50 years: 

varicose veins and venous ulcers 


12.20-13.00 

Prince Pierre Venous symptoms and clinical assessment (PP1.5) 

Chairperson: B. Eklöf 

Moderator: P. Carpentier 

PP1.5-1 P. Carpentier: Venous symptoms: Evolution of the concept 

PP1.5-2 N. Danziger: Pathophysiology of pain in chronic venous disease 

PP1.5-3 M. Vasquez, J.J. Guex: Our obligation to follow clinical outcome 

in venous disease 

PP1.5-4 B. Eklöf: CEAP Classification: what is the future? 

Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)

13.00-14.00 

Camille Blanc STD Pharmaceutical Symposium (Lunch session) (CB1.6) 

Foam Sclerotherapy in 2009 

Chairperson: L. Tessari 

CB1.6-1 P. Coleridge-Smith: Foam Sclerotherapy- the State of the Art 

CB1.6-2 A. Cavezzi: Foam Sclerotherapy in Italy with Post Sclerotherapy Compression 

CB1.6-3 M. Perrin: Recurrent Varicose Veins - Foam Sclerotherapy 

CB1.6-4 A. Bradbury: Foam Sclerotherapy treatment in varicose veins-results 

from 1200 cases 

Panel Discussion & Question 

13.00-15.00 

Auric Council meeting (by invitation: presidents of member societies and board members) 

14.00-15.00 

Presentation of posters by authors: posters DIA 1 to 16 

Chairpersons: M. Schadeck, H. Gerlach 

Discussants : P. Raymond-Martimbeau, F. Vin 

MONDAY, AUGUST 31 ST 


14.00-16.00 

Prince Pierre Free Paper Session: Endovenous Procedures 1 - Diagnosis and Anesthesia (PP1.7) 

Chairperson: R. Weiss 

Moderator: S. Kaspar 

PP1.7-1 C. Lebard: Apport de la mesure échodoppler du diamètre de la grande veine 

saphène pour le calcul d’énergie au cours des traitements endoveineux 

PP1.7-2 J. Ferreira: Ultrasound signals to control the closure process in real time 

in endovenous ablations 

PP1.7-3 G Peruzzi: Endovenous laser ablation of incompetent saphenous veins. inclusion 

criteria by preoperative duplex examination 

PP1.7-4 G. Serpieri: Auto-fill syringe for echoguided tumescent local anesthesia during 

endovenous laser procedure in the treatment of lower limbs varicose veins 

PP1.7-5 J. Ferreira: Selective nerve block under us guidance to perform endovenous 

laser ablation 

PP1.7-7 P.W. Sridhar: Patient preference for local or general anaesthesia during 

endovenous laser ablation and phlebectomy of symptomatic varicose veins 

PP1.7-8 J. Klein: Maximum safe lidocaine dosage for tumescent anesthesia without 

liposuction is 45 mg/kg 

PP1.7-9 G. Serpieri: Endovascular technologies for lower limbs varicose veins treatment 

PP1.7-10 M.Vuylsteke: Endovenous laser treatment: a morphological study 

in an animal model 

PP1.7-11 K. Kikuchi: Clinical comparison of long pulse nd: yag laser versus foam 

sclerotherapy in the treatment of leg veins 

Apollinaire Free Paper Session: Sclerotherapy 1- Basic consideration (AP1.7) 

Chairperson: T. Yamaki 

Moderator: F.X. Breu 

AP1.7-1 F. Bastos: Refléxions sur l’inclusion sociale par la mousse sclerosante 

AP1.7-2 S. Sadoun: Proposition of a mathematical model to calculate the efficacy 

of the sclerosing foam by analogy with the laser biological effect 

AP1.7-3 F. Passariello: Geometrical properties of sclerosing foam in several drainage 

phases in constrained or free environments 

AP1.7-4 K. Parsi: The lytic effects of detergent sclerosants on erythrocytes, platelets, 

endothelial cells and microparticles are attenuated by albumin and other plasma 

components in vitro 

AP1.7-5 K. Parsi: In vitro effects of detergent sclerosants on antithrombotic mechanisms 

AP1.7-6 D. Hill: Effect of a 5 micron filter on CO2 sclerosant foam stability 

AP1.7-7 L. Tessari: “Tessari method for foam sclerotherapy” 

(10 years of history of technology that changed the world of phlebology) 

11

12 



AP1.7-8 A. Cavezzi: Variables in foam sclerotherapy with Tessari method: experimental data 

AP1.7-9 G. Gachet: Recommendations on the endovascular treatment of varicose veins 

by echo-guided injections of sclerosing foam: the Grenoble Consensus of expert 

2008 version 

AP1.7-10 G. Gachet: The SOV concept: an easier safer method for abolition of great 

saphenous incompetence with echo guided sclerotherapy 

AP1.7-11 R. Milleret: Obliteration of varicose veins by hyperheated steam 

Genevoix Free Paper Session: Compression Treatment 1 - Pressure measurements (GE1.7) 

14.00-16.00 Chairperson: Z. Maksimovic 

Moderator: A. Cornu-Thénard 

GE1.7-1 G. Mosti: Superiority of short-stretch bandages to improve venous pumping 

function 

GE1.7-2 B. Partsch: Superposition of two light stockings. Measurement of interface 

pressure and stiffness in vivo and in vitro 

GE1.7-3 J.F. Uhl: Superimposition of MCS in vivo: interface pressure and stiffness index 

measurements 

GE1.7-4 M. Juenger: Interface pressure of three different multi-layer bandage systems 

in healthy volunteers ; results of a prospective randomized clinical study 

GE1.7-5 G. Mosti: Which is the minimal compression pressure to improve venous pumping 

function in patients with venous insufficiency? 

GE1.7-6 A. Cornu-Thénard: Hemodynamic effects of medical compression stockings in 

varicose veins 

GE1.7-7 D. Milic: The influence of different interface pressure values on venous leg ulcers 

healing when treated with compression therapy 

GE1.7-8 S. Reich-Schupke: The resting pressure exerted by round knitted moderate 

compression stockings on the lower leg in clinical practice - results of an 

experimental study 

GE1.7-9 F. Chleir: Is the pression of compressotherapy after a deep venous thrombosis 

influence the importance of the post-thrombotic syndrome? 

GE1.7-10 C. Lim: A summation analysis of compliance and complications with compression 

hosiery for chronic venous disorders 

GE1.7-11 G. Mosti: MRI shows narrowing of leg veins by compression depending on exerted 

pressure and body position 

GE1.7-12 F. Vin: Observational study of the venous disease evolution during pregnancy with 

or without class 2 compression stockings 

14.30-15.15 

Camille Blanc Pierre Fabre Symposium (first part) (CB1.8) 

Venous ulcer: the final stage in chronic venous disease - Managing it in 2009 

Chairperson: Patrick Carpentier 

CB1.8-1 A. Nicolaides: From pathophysiology to clinical evaluation 

CB1.8-2 P. Blanchemaison: Therapeutic Management of venous ulcer 

15.30-16.15 

Camille Blanc Pierre Fabre Symposium (second part) (CB1.9) 

Compression therapy: new device 

Chairperson: H. Partsch 

CB1.9-1 I. Quéré 

15.30-17.30 

Scotto Session of the Latin American Chapter (SC1.9) 

The Varicose syndrome: The Latin America overview of the Diagnosis 

and Management 

Chairpersons: A. Scuderi, E. Altmann Canestri, R. Simkin 

SC1.9-1 N. Rosli: Foam: State of the art in Argentina 

SC1.9-2 A. Shapira: Management of the superficial venous insufficiency in 2009 

An overview 

SC1.9-3 J. Ulloa: Poor stability of Polidocanol foam as compared with 

Lapidium Cloridrate

SC1.9-4 F. Flota Cervera: The prevalence of Lymphoedema in Primary Varicose Disease 

and the efficacy of Calcium Dobesilate on the resolution of lymphatic edema 

SC1.9-5 V. Canata: Varicose veins disease overview of treatment in Paraguay 

SC1.9-6 V. Ibañez Esquembre: Inclusion and exclusion criteria of the endo laser 

management of the varicose syndrome 

SC1.9-7 R. Varnagy: Surgery of Varicose Veins. The History of the “pop star” 

SC1.9-8 M. Bravo: Prophylaxis of DVT in surgery 


16.30-17.15 

Apollinaire Max Ratschow Medal Session (Collegium Internationalis Angiologiae) (AP1.10) 

Chairperson: E. Rabe 

AP1.10-1 J.L. Villavicencio: Pelvic venous disorders: the desperate plea of women 

with the nutcracker syndrome 

Laudatio by E. Rabe 

16.30-18.30 

Prince Pierre Free Paper Session: Endovenous Procedures 2 - Comparative Studies (PP1.11) 

Chairperson: S. Schuller-Petrovic 

Moderator: F. Pannier 

PP1.11-1 R. Kikuchi: Clinical comparison of radiofrequency ablation (RFA) versus 

endovenous laser ablation (EVLA) in great saphenous vein insufficiency treatment 

PP1.11-2 R. Gonzalez: Endovenous laser and echo-guided foam 



PP1.11-3 L. Kabnick: 980nm laser vs. radiofrequency for endothermal venous ablation 

of the GSV: are the recovery results similiar? 

PP1.11-4 J. Christenson: Prospective randomized trial comparing endovenous laser ablation 

and surgery for treatment of primary great saphenous varicose veins- 

2 years follow up 

PP1.11-5 J. Ragg: Comparison of radiofrequency and laser treatment in saphenous veins 

PP1.11-6 M. Mooijj: Randomized clinical trial of endovenous laser ablation (980 nm) 

versus high ligation combined with stripping of the great saphenous vein 

with tumescent anaesthesia 

PP1.11-7 K. Rass: Endovenous laser ablation versus high ligation and stripping of the great 

saphenous vein: 2 year results of the relacs study 

PP1.11-8 J. Tesmann: Bipolar radiofrequency obliteration of varicose veins compared to 

endovenous laser treatment: a prospective study emphasizing on occlusion 

rates, side-effects and stability of the resulting stump 

Camille Blanc ICC Symposium: New methods to evaluate compression therapy (CB1.11) 


Moderator: R. Damstra 

CB1.11-1 H. Partsch: Measurement of interface pressure 

CB1.11-2 J.P. Benigni: Friction index of medical compression stockings 

CB1.11-3 R. Damstra: Compression pressure in lymphoedema of the upper 

and lower extremitites 

CB1.11-4 J.F. Uhl: 3 D-CT for demonstrating compression effects 

CB1.11-5 F. Lurie: MRI for detecting hemodynamic effects of intermittent pneumatic 

compression 

CB1.11-6 G. Mosti: Haemodynamic effects of compression depending on interface pressure 

CB1.11-7 M. Jünger: Dermal microcirculation in Chronic Venous Insufficiency (CVI) 

and peripheral arterial occlusive disease: change of dermal fluxmotion 

by compression bandages 

CB1.11-8 E. Rabe: Does Compression influence progression of venous diseases? 

13

14 



Bosio Session of the Asian and Australasian Chapter (BO1.11) 

16.30-18.30 Chairpersons: B.B. Lee, M. Malouf 

BO1.11-1 T. Yamaki: High peak reflux velocity in the proximal deep veins is a strong 

predictor of advanced postthrombotic sequelae 

BO.1.11-2 T. Ogawa: Relation between radiofrequency and laser ablated venous diameter 

and recanalization 

BO1.11-3 K.T Kim: The current management of varicose vein surgery for leg vein in Korea 

BO1.11-4 Y. Gu: Surgical treatment of severe acute deep venous thrombosis in lower 

extremity 

BO1.11-5 M. Patel: Helps and hinderances to the diagnosis and treatment of venous 

disease in India 

BO1.11-6 K. Parsi: Interactions of sclerosants with the coagulation system 

BO1.11-7 N. Piller: Early detection of subtle (pre-clinical) fluid changes in legs using 

Bioimpedance Spectroscopy 

BO1.11-8 J. Barrett: The natural history of thrombosis in the proximal non-lasered 

saphenous vein segment following EVLA 

Genevoix Free Paper Session: Venous Anatomy and Epidemiology (GE1.11) 

16.30-18.30 Chairperson: S. Ricci 

Moderator: A. Caggiati 

GE1.11-1 A. Zanon: Brief historical excursus on the discovery of the blood circulation 

GE1.11-2 G. Schweighofer: The thigh extension - from Giacomini’s observation to clinical 

anatomy of the present 

GE1.11-3 C. Tasch: The ostial valve of the great saphenous vein 

GE1.11-4 M. Vakhitov: Anatomic causes of the varicose vein disease development in lower 

extremities 

GE1.11-5 A. Van Rij: Venous Perforators in normal lower limbs - Ultrasound characterisation 

and comparison with resin caste anatomy 

GE1.11-6 S. Ricci: Echographic sural nerve visualisation: method and anatomical aspects 

GE1.11-7 P. Carpentier: Risk factors for incident chronic venous disorders: results from 

the basel follow-up study 

GE1.11-8 M. Lefebvre-Villardebo: Prevalence of perineal varices in varicose disease 

of lower limbs 

GE1.11-9 V. Stvrtinova: How to improve the awareness of chronic venous disease - 

an experience from Slovak Republic 

GE1.11-10 J.F. Uhl: Anatomical variations of the femoral vein above the knee 

GE1.11-11 J. Nigro: Hemodynamic study of the reflux circuit in great saphenous vein in the 

essential venous insufficiency 

GE1.11.12 A. Kokkosis: The distribution and significance of varicosities in the saphenous 

trunks 

17.15-18.30 

Apollinaire Free Paper Session: Venous Malformation (AP1.12) 

Chairperson: J.L. Villavicencio 

Moderator: D. Loose 

AP1.12-1 Z. Maksimovic: Varicose venous disease caused by congenital vascular 

malformations 

AP1.12-2 R. Mattassi: Venous malformations are often coupled with lymphatic dysplasias 

AP1.12-3 S. Sapelkin: Magnetic resonance imaging in diagnostic of vascular malformations 

AP1.12-4 L. Corcos: The role of diode 808 nm endovenous laser in the treatment 

of congenital venous malformations 

AP1.12-5 A. Sierra: Safety of ultrasound guided microfoam sclerotherapy (UGMS) in children 

with venous malformations 

AP1.12-6 R. Malgor: Surgical treatment of venous malformations in Klippel-Trénaunay 

Syndrome (KTS)


Tuesday, September 1 st 

07.30-08.45 


O. Maleti: The Neovalve in PTS - tips and tricks 

M. Perrin: discussant moderator 


H. Partsch: My technique in compression treatment - bandages or stockings 

G. Mosti: discussant moderator 


M. Goldman: Esthetic treatments and phlebology practice 

M. Malouf: discussant moderator 


09.00-11.00 

Prince Pierre Thromboembolic Disease (PP2.2) 

Chairperson: W. Blättler 

Moderator: M. Meissner 

PP2.2-1 A. Comerota: Current status of thrombolysis and thrombectomy in iliofemoral DVT 

PP2.2-2 N. Baekgaard: Catheter directed thrombolysis in iliofemoral DVT 

PP2.2-3 S. Vedantham: Endovascular DVT interventions 

PP2.2-4 H. Décousus: New anticoagulants in the treatment of venous thromboembolism 

PP2.2-5 J. Lohr: Calf vein thrombosis - how to treat 

PP2.2-6 R. Bauersachs et al: TULIPA registry - recent practice in diagnosis 

and treatment of DVT 

PP2.2-7 B. Eklöf: Anything new in travel related venous thromboembolism? 

PP2.2-8 M. de Maeseneer: How to treat superficial thrombophlebitis? 



11.30-12.00 


Chairperson: M. Malouf 

N. Labropoulos: Why do varicose veins develop? 


12.00-13.00 

Prince Pierre UIP Consensus Varicose Veins (PP2.4) 

Chairpersons: P. Gloviczki, H. Neumann 

PP2.4-1 P. Gloviczki: UIP consensus on diagnosis and treatment of varicose veins 

PP2.4-2 M. de Maeseneer: Classification of duplex findings after treatment of saphenous 



13.00-14.00 

Apollinaire Session of the German Society of Phlebology (AP2.5) 

Board Meeting (by invitation only) 

15

16 

TUESDAY, SEPTEMBER 1 ST 


Bosio VNUS workshop (BO2.5) 

13.00-14.00 Chairpersons: T. Proebstle, M. Vasquez 

BO2.5-1 J. Alm: Small Saphenous Veins with ClosureFAST 

BO2.5-2 T. Proebstle: ClosureFAST, 3 years follow up 

BO2.5-3 M. Vasquez: Perforators with the VNUS RFS catheters 

BO2.5-4 O. Goeckeritz: Closure vs. Laser (Recovery Study) 

BO2.5-5 T. Proebstle: Hands On (Tissue Interaction) 

14.00-15.00 

Presentation of posters by authors: posters DIA 17 to 31 


Discussants: T.Yamaki, M. Dalsing 

14.00-15.30 

Camille Blanc Servier Symposium: Management of chronic venous disease: 

therapeutic recommendations (CB2.6) 

Chairpersons: A.N. Nicolaides, E. Rabe 

E. Rabe: Introduction 

CB2.6-1 A. Comerota: What’s new in guidelines? 

CB2.6-2 A.A. Ramelet: Management of chronic venous disease: the example of Daflon 500mg 

CB2.6-3 A. Jawien: Unmet needs in assessment of symptoms and signs 

CB2.6-4 A.N. Nicolaides: Recent guidelines in chronic venous disease: 

the place of Daflon 500 mg 

A.N. Nicolaides: Conclusion 

14.00-16.00 

Prince Pierre Free Paper Session: Sclerotherapy 2 - Miscellaneous (PP2.6) 

Chairperson: C. Hamel-Desnos 

Moderator: A. Cavezzi 

PP2.6-1 M. Lefebvre-Vilardebo: Intra-operative sclerotherapy of post-surgical inguinal 

neovascularization: 2 years results 

PP2.6-2 F. Zini: Surgery or sclerotherapy for groin recurrent varicose veins? 

PP2.6-3 E. Ivanov: A comparison of sclerotherapy modifications in the treatment of venous 

stasis dermatitis 

PP2.6-4 N. Bunke: Non-saphenous sclerofoam treatment of lower extremity 

primary varicose veins 

PP2.6-5 M. Stücker: Efficiency and safety of an accelerated therapy regime for tributaries: 

polidocanol-0,5%-foam with injections every 2 nd to 3 rd day 

PP2.6-6 P. Antignani: The role of foam sclerotherapy in ederly patient (over70) with severe 

disabling CVI 

PP2.6-7 H. Bernbach: Compression in sclerotherapy of the sapheno-femoral junction: 

our experience 

PP2.6-8 L. Moro: CO2 foam sclerotherapy in patients over 70 years old: efficacy and safety 

PP2.6-9 J.De Abajo Fernandez: Sequential sclerosant treatment of varices in lower limbs 

secondary to pelvic venous desease 

PP2.6-10 N. Haruta: Significance of severing insufficient perforating veins in the treatment 

of varicose veins by sclerotherapy, subtitle: condition of insufficient perforating 

veins after sclerotherapy 

PP2.6-11 J. Klode: Polidocanol foam sclerotherapy as a new and effective treatment of post 

surgical lymphocutaneous fistula: first results of a clinical trial 

PP2.6-12 J. Ulloa: Hand veins: new approach with lapidium clorhidrate foam



Apollinaire Free Paper Session: Endovenous Procedures 3 - Prospective Studies (AP2.6) 

14.00-16.00 Chairperson: S. Zimmet 

Moderator: L. Kabnick 

AP2.6-1 P. Chapman-Smith: Endovenous laser ablation (EVLA) with 1320nm in 

the treatment of varicose veins - a 3 years prospective study 

AP2.6-2 F. Vin: Endovenous laser treatment of greater saphenous veins. Results at 2 years 

AP2.6-3 G. Agus: Endovenous laser treatment of saphenous and perforators reflux for leg 

ulcers in primary chronic venous insufficiency 

AP2.6-4 T. King: Experience with concomitant ultrasound-guided foam sclerotherapy 

and endovenous laser treatment in chronic venous disorder and its influence 

on Health Related Quality of Life (HRQL): interim analysis of more than 1000 

consecutive procedures 

AP2.6-5 S. Mancini: Endovenous laser treatment of varicose veins. Results to 5 years 

AP2.6-6 S. Jianu: Endovenous laser treatment versus surgery for incompetent great and 

small saphenous veins 

AP2.6-7 S. Kaspar: Six years experience with endovenous laser ablation in Czech Republic 

AP2.6-8 I. Kabnick: 1010 980nm laser saphenous ablations with 12-24 months duplex 

examination 

AP2.6-9 T. King: Progression and recurrence of vein disease in patients treated with 

endovenous laser ablation: two-four year experience. Is there a place for 

the phrase recurrent varices after laser or reval? 

AP2.6-10 R. Kikuchi: Clinical comparison of thigh only versus extended endovenous laser 

ablation (EVLA) in great saphenous vein insufficiency treatment 

AP2.6-11 C. Stuckey: Incompetent perforators - the unseen villain 

AP2.6-12 S. Vayuvegula: early results of the new 1470nm radial fiber on truncal reflux using 

only 3W of energy delivery 

Bosio Session of the German Society of Phlebology 

14.00-16.00 Varicose Veins and Venous Ulcers (BO2.6) 

Chairperson: H. Gerlach 

Moderator: H. Kluess 

BO2.6-1 A. Ladwig: Prevalence of chronic venous insufficiency in the population 

of north-east Germany (study of health in Pomerania) 

BO2.6-2 E. Rabe et Al: Incidence of varicose veins and CVI in the Bonn vein study II 

BO2.6-3 H. Kluess: German guidelines for diagnosis and treatment of varicose vein disease 

BO2.6-5 N. Frings: Venous surgery in very old patients (> 70 years) 

BO2.6-6 G. Gallenkemper: German guidelines on diagnosis and treatment of venous ulcers 

BO2.6-7 A. Obermayer: A “sourcing” for the responsible venous reflux causing leg ulcers 

BO2.6-8 A. Obermayer: Venous reflux surgery promotes venous leg ulcer healing despite 

reduced ABPI 

BO2.6-9 H. Hermanns: Ulcer surgery and very old patients (80 -100 years) 

- a practical procedure? 

BO2.6-10 W. Blättler, D. Lüscher, E.O. Brizzio, F. Amsler, T. Willenberg: Healing of venous 

ulcers is determined in part by genetic polymorphisms of factor XIII and iron 

metabolism 

Genevoix Short free paper Session I (GE2.6) 

14.00-16.00 Chairperson: A. Mansilha 

Moderator: P. Coleridge-Smith 

GE2.6-1 M. Goldman: Long term follow-up study of intravascular 1320-nm laser closure 

of the great saphenous vein 

GE2.6-2 M. Goldman: Efficacy of additional graduated compression after sclerotherapy 

treatment of reticular and telangiectatic leg veins 

GE2.6-3 M.Goldman: Complications of foam sclerotherapy for reticular veins 

GE2.6-4 A. Cornu-Thénard: A CA and CB for each C class of the C of CEAP classification 

17

18 



GE2.6-5 M. Cazaubon: The CEAP classification in daily phlebology practice: a Franco-Italian 

multicenter survey on the prevalence of isolated varices (C2) and complicated 

varices (C2+) 

GE2.6-6 R.F. Vega: Prevalence of varicose veins in a diagnostic unit in Mexico City 

GE2.6-7 S. Sadoun: Epidemiological study of the seasonnal variation of the incidence 

and the prevalence of venous ulcer: the Vesuve study (variation epidémiologique 

saisonnière de l’ulcère d’origine veineuse) 

GE2.6-8 E. Bernardini: Evolution of primary venous insufficiency: ascending development. 

Observational and hemodynamic study 

GE2.6-9 V. Ivan: Posterior accessory saphenous vein of the leg: implications in the 

pathogenic sever trophic disorders 

GE2.6-10 J. Nigro: Hemodynamic study of the reflux circuit in short saphenous vein in the 

essential venous insufficiency 

GE2.6-11 E. Brizzio: Internal Calf Pump Performance (ICP) evaluated togheter with 

ecodoppler color 

GE2.6-12 F. Van Sprundel: Pseudo-phlegmasia caerulea dolens after cardiac catheterization 

GE2.6-13 N. Morrison: Relationship between number of pregnancies and great saphenous 

vein diameter 

GE2.6-14 I. Zhang: The research of erythrocytes immune function in chronic venous 

insufficiency of the lower extremities 

GE2.6-15 M. Griffin: The challenges associated with venous duplex scanning 

GE2.6-16 N. Piller: Differential diagnosis: what if the swelling is lymphoedema, lipoedema or 

myxoedema? 

GE2.6-17 K. Hartmann: Treatment of incomplete trunk varicosity with combined foam 

sclerotherapy and vnus closure fast technique 

GE2.6-18 E. Menegatti: Echo-color doppler criteria for diagnosis of chronic cerebrospinal 

venous insufficiency 

GE2.6-20 A. Cornu-Thénard: International phlebological file , or how to make CEAP friendly 

and easy to use 

GE2.6-21 P. Bhaskaran: Assessment of microcirculation on sternal wound healing after open 

chest cardiac surgery using laser doppler imaging system 

GE2.6-22 P. Bhaskaran: Clinical use of laser doppler scanner as a diagnostic and prognostic 

tool for peripheral vascular disease 

GE2.6-23 S. Sadoun: Treatment for panniculitis, using mesotherapy : a study of 10 

consecutive patients 

15.30-16.00 

Camille Blanc Lecture (CB2.7) 

Chairperson: A. Scuderi 

C. Allegra: Microcirculation in Phlebology 


16.30-18.30 

Prince Pierre Free Paper Session: Sclerotherapy 3 - Safety aspects (PP2.8) 

Chairperson: M. Schadeck 

Moderator: K. Hartmann 

PP2.8-1 J.J. Guex: The French polidocanol registry on long term side effects - 

a survey covering 3357 patient years 

PP2.8-2 M. Schadeck: Complications of duplex guided sclerotherapy of the small 

saphenous vein. Study of a population of 4984 patients 

PP2.8-3 K. Parsi: Detergent sclerosants interfere with natural fibrinolytic mechanisms but 

induce clot lysis in vitro



PP2.8-4 C. Hamel-Desnos: Sclerotherapy of varicose veins in patients with documented 

thrombophilia. A prospective controlled randomized study of 105 cases 

PP2.8-5 P. Thibault: Perivenous tumescent compression to enhance sclerotherapy results 

and reduce adverse effects 

PP2.8-6 L.Tessari: May sclerotherapy cause a pulmonary injury? Preliminary results with 

dynamic scans of the thorax using 99mtc pertecnethate 

PP2.8-7 D. Wright: Polidocanol does not remain on the surface of bubbles free in the 

venous blood 

PP2.8-8 A. Cornu-Thénard: Foam Echoguided Sclerotherapy (FES): how to avoid overdoses 

before injections? 

PP2.8-9 D. Wright: Prevalence of patent foramen ovale (right to left shunt) is higher 

in patients with varicose veins 

PP2.8-10 L. Tessari: Chasing the bubbles in foam sclerotherapy 

PP2.8-11 P. Raymond-Martimbeau: Transient adverse effects positively associated with 

patent foramen ovale after ultrasound-guided foam sclerotherapy 

Camille Blanc Free Paper Session: Venous Pathophysiology (CB2.8) 

16.30-18.30 Chairperson: M. Rosenblatt 

Moderator: F. Boccardo 

CB2.8-1 F. Chleir: Modification of long saphenous vein diameter during pregnancy 

CB2.8-2 F. Passariello: The role of circumflex femoral veins in the SFJ incompetence. 

A case report 

CB2.8-3 T. Iwai: Popliteal vein symptomatic & asymptomatic entrapment, and popliteal vein 

thrombosis caused by vein entrapment with or without soleus muscle vein dilatation 

CB2.8-4 A.C. Shepherd: Anatomical reflux does not predict the functional impact of venous 

disease 

CB2.8-5 L. Moro: Early stages of venous disease are associated with arterial endothelial 

dysfunction in healthy adults 

CB2.8-6 M. Cappelli: The pathophysiological role of extra-saphenic perforator veins 

CB2.8-7 A. Vital: Unmyelinated C fibers and inflammatory cells are present in the wall of 

human varicose veins. A clinico-pathological study 

CB2.8-8 S. Schulz: Venous flow pattern and heart disease 

CB2.8-9 B. Kahle: Non-invasive bioengineering assessment of the skin barrier function in 

patients with chronic venous insufficiency 

CB2.8-10 G. Jones: Conscious venous blood pressure measurements in a porcine model of 

superficial varicose veins 

CB2.8-11 A. Van Rij: Proteomic comparison of varicose veins in humans and in those that 

develop in a new porcine model 

CB2.8-12 Y. Herouy: Angiogenesis and venous insufficiency 

Apollinaire Free Paper Session: Endovenous Procedures 4 - Wavelength and new Fibres (AP2.8) 

16.30-18.30 Chairperson: N. Morrison 

Moderator: M. Stuecker 

AP2.8-1 A Sanchez-Galan: Does the wavelength influence the results when treating internal 

saphenous vein insufficiency with endovenous laser treatment? A prospective 

analysis comparing three series 

AP2.8-2 S. Kaspar: Laser wavelength and its influence on outcome of endovenous ablation 

of varicose veins 

AP2.8-3 J. Ferreira: Endovascular vein ablation using a 1470 diode laser and radial fibers - 

a new era is arising? 

AP2.8-4 S. Shokoku: Treatment of the varicose veins using 1470nm diode laser - short 

term results 

19

20 



AP2.8-5 F. Pannier: Endovenous Laser Ablation (EVLA) of the GSV with a 1470 nm diode 

laser and a radial emitting fiber. Follow-up after 6 month and comparison with the 

bare fibre 

AP2.8-6 J. Soracco: Endovenous laser treatment with 1470nm laser and external 

chromophore. Preliminary study 

AP2.8-7 A. Hoch: Effectiveness and clinical outcome following endovenous therapy 

of primary varicose veins: first results of a randomised, prospective study 

comparing the vnus closure fast system, 980nm and 1470nm lasers and 

conventional surgery 

AP2.8-8 U. Maurins: Does the laser power influence the results of Endovenous Laser 

Ablation (EVLA) of incompetent saphenous veins with the 1470 nm diode laser 

and radial fiber - a prospective randomized study comparing 10 and 15 watt. 5 

months follow-up 

AP2.8-9 M. Vuylsteke: Endovenous laser ablation: intraluminal centralisation of fibre-tip can 

perfectionate the technique, a histological study 

AP2.8-10 M. Vuylsteke: Endovenous laser treatment: is there a clinical difference using a 1500nm 

laser versus a 980nm diode laser? A multicentric prospective comparative trial 

AP2.8-11 J. Ragg: Comparison of 810 to 1470 nm laser systems in identical veins 

AP2.8-12 L. Corcos: The past, present and future of 808 nm diode laser in the treatment of 

varicose veins of the lower limbs 

Bosio Session of the German Society of Phlebology 

16.30-18.30 Endovenous treatment: Obesity and CVI (BO2.8) 

Chairperson: A.A. Ramelet 

Moderator: S. Schuller Petrovic 

BO2.8-1 A.A Ramelet: Polidocanol - rare adverse effects 

BO2.8-2 S. Schuller Petrovic: Tissue effects after subcutaneous injection with foam or liquid 

Polidocanol 

BO2.8-3 C. Jeanneret: The Swiss registry of thermic endovenous catheter interventions in 

varicose veins, a multicenter case control study 

BO2.8-4 I. Flessenkämper, M. Hartmann, D. Stenger: RCT for differentiated open and 

endoluminal therapies for degenerative disease of the great saphenous veins 

BO2.8-5 K. Göstl: Obesity: a risk factor for CVI? 

BO2.8-6 J. Christenson: Relationship between body mass index and the severity 

of chronic primary venous disease 

BO2.8-7 H. Hermanns: Obesity and varicose vein surgery 

BO2.8-8 H. Hermanns: Varicose vein surgery and obesity - experience with a new boazul 

cuff in leg circumference up to 90 cm 

BO2.8-9 J. Herouy: Leg comparison of region, gender and age in Germany by digital 

3D-measurements to venous diagnosis 

Genevoix Free Paper Session: Venous Diagnosis 1 (GE2.8) 

16.30-18.30 Chairperson: G. Gallenkemper 

Moderator: E. Brizzio 

GE2.8-1 D. Milic: Risk factors related to the failure of venous leg ulcers to heal with 

compression treatment 

GE2.8-2 J.F. Uhl: New virtual computer tools to investige venous patients 

GE2.8-3 K. Miyake: Superficial venous score 9-1: A classification system that improves 

cosmetic treatment of leg vein lesions 

GE2.8-4 S. Reeder: The relation between CEAP and the gold standard ambulatory venous 

pressure measurement.


GE2.8-5 J.F. Uhl: The static disorders of the foot: a major risk factor of CVI 

GE2.8-6 C. Blazek: Several dermatological applications of functional skin microcirculation 

mapping using PPGI method 

GE2.8.7 V. Blazek: Space-resolved low frequency blood volume rhythms in skin perfusion 

obtained by camera based optical sensing (photoplethysmography imaging) 

GE2.8-8 G. Avruscio: A new method for studying Chronic Venous Insufficiency (CVI): 

Telemetric Light Reflex Rheography (TLRR). 

GE2.8-9 R. Di Stefano: Dynamic foot – exerciser: a validation study and testing in disuse 

oedema patients 

GE2.8-10 T. Yamaki: Increased calf muscle deoxygenation during light-intensity exercise 

suggests increased venous reflux flow in advanced human chronic venous 

disease 

GE2.8-11 M. Pejic: The incidence of deep vein thrombosis in patients undergoing 

laparoscopic procedures 

20.00 

Sporting Montecarlo, Salle des Etoiles 

UIP 50 th Anniversary Gala dinner (ticketed event) 

Shuttle bus will be provided from the hotels. 


21

22 


Wednesday, September 2 nd 

07.30-08.45 


J.F. Uhl: 3D-imaging of the venous system 

A. Caggiati: discussant moderator 


T. Proebstle: Closure Fast ® , indications and how to do it 

N. Morrison: discussant moderator 


N. Labropoulos: Duplex of the deep veins - tips and tricks 

D. Neuhardt: discussant moderator 


09.00-09.45 

Prince Pierre Special issue in Phlebology (PP3.2) 

Chaiperson: J. Cabrera 

Moderator: A. Ramelet 

PP3.2-1 A.Frullini: Enhanced sclerosis by vis-sclerotherapy: a new treatment of superficial 

venous insufficiency 

PP3.2-2 S. Elias: A new pharmacomechanical method of endovenous ablation: Clarivein® 

PP3.2-3 F. Chleir: Aged degenerating macula and eyes venous insufficiency 


09.45-11.00 

Prince Pierre Chronic Cerebro-Spinal Venous Insufficiency (CCSVI): 

diagnosis and treatment (PP3.3) 

Chairperson : P. Zamboni 

Moderator: B.B. Lee 

PP3.3-1 M Simka: CCSVI and Multiple Sclerosis: theoretical and practical issues 

PP3.3-2 M. Haacke: Cerebral veins and iron deposits explored by advanced MRI-SWI 

PP3.3-3 R. Galeotti: Imaging and endovascular treatment of CCSVI 

PP3.3-4 F. Salvi: Treatment of CCSVI: clinical results on associated multiple sclerosis 



11.30-12.00 


Chairperson : M. de Maeseneer 

W. Blättler: Asymptomatic deep venous thrombosis 


12.00-13.00 

Prince Pierre UIP Consensus Curriculum in Phlebology (PP3.5 ) 

Chairperson: S. Raju 

Moderator: K. Parsi 

PP3.5-1 K. Parsi: Curriculum in Phlebology (UIP consensus) 

PP3.5-2 F. Lurie: UIP consensus on diagnosis and treatment of deep venous insufficiency


PP3.5-3 E. Rabe, R. Bauersachs, F. Pannier: DAPS - Dalteparin in patients with Superficial 

Leg Vein Phlebitis (SVP) in addition to compression treatment - a placebocontrolled 

phase III study 


13.00-14.00 

Apollinaire Session of the German Society of Phlebology (AP3.6) 

Bauerfeind Award 

Hartmann Price 

13.00-15.00 

Auric Council meeting (by invitation: presidents of member societies and board members) 

14.00-15.00 

Presentation of posters by authors DIA 32 to 46 


Discussants: S. Simkin, G. Agus 

WEDNESDAY, SEPTEMBER 2 nd 

14.00-16.00 

Prince Pierre Medi Symposium (PP3.7) 

Compression therapy after surgery and endovenous procedures 


PP3.7-1 E. Rabe: What is the rationale for post-procedural compression? 

PP3.7-2 P. Coleridge Smith: What is the evidence? 

PP3.7-3 N. Morrison: Different forms of compression after different procedures? 

PP3.7-4 S. Zimmet: How I do it 

PP3.7-5 M. Neumann: Requirements of compression garments in the post-procedural 

management 

PP3.7-6 JP Benigni: A new compression device 

PP3.7-7 M. Lugli: What is the rationale for the crossed-tape technique? 

PP3.7-8 G. Mosti: Comparison of three different forms of compression after varicose vein 

surgery 

Camille Blanc Free Paper Session: Endovenous Procedures 5: RFA (CB3.7) 

Chairperson: T. Proebstle 

Moderator: O. Pichot 

CB3.7-1 R.Weiss: Ten year experience with endovenous ablation: RF and laser 

CB3.7-2 T. Proebstle: Radiofrequency Segmental Thermal Ablation (RSTA) of great 

saphenous veins: two year follow-up 

CB3.7-3 T. Noppeney: Metaanalysis of the results after radiofrequency obliteration for 

treatment of varicosis 

CB3.7-4 K. Brachmann: Histological changes after endovenous radiofrequency therapie 

(VNUS closure/ closure fast) 

CB3.7-5 J. Alm: Closure fast. A novel concept of endovenous thermal ablation for short 

saphenous veins. Techniques and initial clinical experience 

CB3.7-6 M. Stücker: The extent of necrosis of the vein-wall is determined by power and 

time of the applied bipolar radiofrequency-induced thermotherapy - histological 

results of an ex-vivo experiment 

CB3.7-7 S. Ray: The role of endovenous ablation in the treatment of recurrent varicose 

veins 

23

24 



CB3.7-8 A. Shepherd: Radiofrequency ablation or endovenous laser therapy for varicose 

veins? 

CB3.7-9 L. Hnatek: Two years experience and one year follow-up results with 

radiofrequency induced thermotherapy (RFITT) of varicose veins 

CB3.7-10 J. Alm: Recurrence varicosis of Greater Saphenous Vein (GSV) after endovenous 

radiofrequency (RF) ablation - retreatment and comparison with RFITT 

CB3.7-11 L. Hnatek: Endovascular radiofrequency induced thermo-therapy (RFITT) for the 

treatment of perforating veins 

Apollinaire Free Paper Session: Sclerotherapy 4: Telangiectases and reticular veins (AP3.7) 

14.00-16.00 Chairperson: S. Küpfer 

Moderator: J. Barrett 

AP3.7-1 J.C.M. Chardonneau: Telangiectasias microsclerotherapy treatment: the rules of 3 

AP3.7-2 B. Kahle: Efficacy of sclerotherapy in intradermal varicose veins - a prospective, 

double blinded, placebocontrolled study 

AP3.7-3 E. Rabe: Polidocanol, sodium tetradecyl sulfate and placebo for sclerotherapy of 

C1-varicose veins: a double-blind, randomized, controlled clinical trial (EASI-Study) 

AP3.7-4 D. Schliephake: A new standardized digital imaging system to document treatment 

success after sclerotherapy of C1-varicose veins applied in a double-blind, 

randomized, controlled clinical trial (EASI-Study) 

AP3.7-5 J. Zhang : Polidocanol/lauromacrogol 400 vs. placebo for sclerotherapy of C1 and 

C2 non-saphenous trunk varicose veins: a double-blind, randomized, controlled, 

multi-center clinical trial (esachina study) performed in the P.R. of China 

AP3.7-6 R. Weiss: 24 year retrospective review of safety and efficacy of STS and POL for 

treatment of telangiectasias and reticular veins 

AP3.7-7 G.Bruning: More efficiency through transillumiunation with Veinlite® in 

the sclerotherapie of spider veins 

AP3.7-8 J. Ferreira: Laser Enhanced Sclerotherapy (LES) treatment of telangiectasias 

AP3.7-9 M. Schul: Compression therapy vs. sclerotherapy for isolated refluxing reticular 

veins and telangiectasia: 12 months results of a randomized trial 

AP3.7-10 R. Lonardi: Endo-perivenous laser procedures for teleangectasias treatment 

AP3.7-11 K. Miyake: Clacs guided by the veinviewer: new therapy for cosmetic leg vein 

treatment (4 years experience) 

AP3.7-12 B. Palmieri: Polymerized hyaluronic acid in lower legs teleangiectasia and varicose 

veins treatment 

Bosio Session of the French Society of Phlebology : 

14.00-16.00 1st Part: Cooperative studies of the French Society of Phlebology (BO3.7) 

Chairpersons: J.P. Gobin, J.F. Uhl 

BO3.7-1 O. Pichot , F.A. Allaert, A. Caggiati, S. Chastanet, A. Colignon, D. Creton, J. Garces, 

O. Hartung, P. Pittaluga, B. Rea, J.F Uhl (cooperative study of the French Society 

of Phlebology): Prospective multicenter study for the evaluation of the ASVAL 

method to treat varicose veins : objectives and preliminary protocol 

BO3.7-2 G Gachet: The SOV concept. A new approach for preserving saphenous vein trunk 

BO3.7-3 J.F Uhl ,B. Cales, G. Cohen-Solal, D. Creton, J.P. Gobin, J.C Scialom (cooperative 

study of the French Society of Phlebology) CELON: a new Radio Frequency 

technique for thermical ablation of the great saphenous vein: 

multicenter prospective study about 65 cases: preliminary results 

BO3.7-4 J.P Gobin, J.P Benigni, F.A Allaert (cooperative study of the French Society of 

Phlebology): Prospective case-control study on the effect of sclerotherapy 

on the healing speed of venous ulcers and their recurrence within 1 and 2 years 

BO3.7-5 M. Chahim, J.F Uhl, F.A Allaert (cooperative study of the French Society of Phlebology): 

Correlation between CVD and the static foot disorders


BO3.7-6 F.A Allaert: Methods for the evaluation of utility, usefulness and efficiency of 

venoactive drugs 

BO3.7-7 J.P. Benigni, J.P Gobin, F.A. Allaert (cooperative study of the French Society of 

Phlebology): Results of an observational prospective study of a new venoactive 

food supplementation AXOVEN® 

BO3.7-8 V. Crebassa: New ultrasound technology without Doppler for venous desease 

exploration: the B-Flow 

BO3.7-9 J.L. Gerard, B. Cales, E. Girou: Prevention of infection in outpatient clinic. 

Proposal for guidelines 

Genevoix Free Paper Session: Lymphedema/ Pelvic Veins (GE3.7) 

14.00-16.00 Chairperson: C. Campisi 

Moderator: J. Laredo 

GE3.7-1 N. Piller: When the vascular system is in failure: strategies to improve lymphatic 

transport 

GE3.7-2 A. Ladwig: Therapy of secondary lymphedema of the arm 

GE3.7-3 P. Mortimer: Venous valve failure a phenotype of genotyped lymphoedema 

GE3.7-4 L. Flota Cervera: Mycrocirculatory physiological concepts of lymphedema 

GE3.7-5 C. Campisi: LVA microsurgical indications 

GE3.7-6 J. Krapp: There is now indication for surgery in lymphedema? 

GE3.7-7 V. Melita: Automatic mesotherapy guns, in lower leg mesenchymal treatment: 

indications, protocols and follow up 

GE3.7-8 S. Langendoen: Lipedema: from clinical presentation to therapy 

GE3.7-9 F. Bastos: Anatomie des veins ovariennes humaines 

GE3.7-10 A. Kurklinsky: A case of combined nutcracker and May-Thurner Syndromes in an 

adult with resolution of hemodynamic findings 

GE3.7-11 S. Zubico Ezpelata: Pelvic leaks 



16.30-18.30 

Prince Pierre Free Paper Session: Endovenous Procedures 6: Combined Treatment (PP3.8) 

Chairperson: T. Proebstle 

Moderator: C. Jeanneret 

PP3.8-1 R. Simkin: Combined surgery with endovenous laser, Müller technique 

and videoscopy 

PP3.8-2 M. Parikov: Role on tributaries GSV to formation long stump after endovenous 

laser treatment 

PP3.8-3 C. Hayes: The effect of endovenous laser ablation on the restless legs syndrome 

PP3.8-4 M. Dhobb: Anatomical limits of endovenous laser obliteration in the great 

saphenous vein: combined treatment for optimal results 

PP3.8-5 S. Ray: One-stop treatment of varicose veins by radiofrequency ablation and miniphlebectomies 

PP3.8-6 F. Carrer: The first five minutes of the great saphenous vein after 808 nm diode 

laser ablation. Further details of the histological study 

PP3.8-7 R. Velletaz: 1008 Endovenous Laser Treatment (EVLT) personal experience 

PP3.8-8 R. Simkin: Klipplel Trenaunay syndrome: treatment with endovenous laser 

preliminary results & long term results with the regional segmental skeletization 

technique 

PP3.8-10 R. Shepherd: Is endothermal ablation the answer to patient satisfaction? 

PP3.8-11 J. Ulloa: Use of CO2 laser in lipodermatosclerosis 

PP3.8-12 L. Dzieciuchowicz: The value of ultrasound guided femoral nerve block in patients 

undergoing endoluminal laser ablation of great saphenous vein 

25

26 



Camille Blanc Free Paper Session: Venous Surgery 1 (CB3.8) 

16.30-18.30 Chairperson: A. Van Rij 

Moderator: P. Pittaluga 

CB3.8-1 F. Passariello: Management of spontaneous SFJ/SPJ acute thrombosis - 

a vasculab survey 

CB3.8-2 C. Pereira-Alves: Minimally invasive selective surgery of primary varicose veins of 

lower limbs 

CB3.8-3 G. Tommasi: Hemodynamic and selective surgery of safeno femoral junction in 

patients with portal hypertension 

CB3.8-4 M. Vandendriesche: Surgery of the small saphenous vein, a personal series 

CB3.8-5 A. C. Shepherd: Recruitment to valve trial: the pros and cons of eligibility criteria 

CB3.8-6 C. Lim C: Secondary care treatment of patients with varicose veins in NHS 

England - an NHS website study 

CB3.8-7 J. Avram: Relapsed varicose disease - etiopathogeny, methods of treatment 

CB3.8-8 P. Casoni: Stump evolution after free crossectomy GSV saphenectomy: 

analysis in 500 cases 

CB3.8-9 G. Bruning: Recurrent varicosis and quality of life after varicose surgery: 

6 years follow up 

CB3.8-10 N. Frings: Reduction of neovascularisation at the saphenofemoral junction by 

extensive crossectomy 

CB3.8-11 P. Pittaluga: Surgical treatment for varicose recurrence: is inguinal redo surgery 

justified? 

Apollinaire Bauerfeind Symposium (AP3.8) 

16.30-18.30 The venous ulcer - patient between compression and intervention 

Chairperson: M. Jünger 

AP3.8-1 M. Perrin: Venous Interventions in ulcer patients - what is evidence based? 

AP3.8-2 T. Wentel: Evidence based compression in venous ulcer patient: bandage or 

stocking? 

AP3.8-3 C. Glynn: Pain management of venous ulcer 

AP3.8-4 M. Zutt: Modern wound management and treatment of wound infections 

Requirement and scope of modern wound dress systems in combination 

with efficient compression therapy 

AP3.8-5 M. Jünger: Natural care and protection of skin: advantage of algae ointment 

for the phlebological patient 

AP3.8-6 G. Ebert: Fascinating world of Nanoalgae 

Bosio Session of the French Society of Phlebology: (BO3.8) 

16.30-18.30 2 nd Part: Treatment of chronic venous disorders: French and Russian convergences 

Chairpersons: A.Shimanko, J.P. Benigni 

Moderators: M. Schadeck, R. Dremov 

BO3.8-1 M. Schadeck: Duplex guided sclerotherapy: respective indications of liquid and 

foam 

BO3.8-2 S. Krylov: Is varicose vein pattern implicated with efficacy of foam sclerotherapy 

of saphenous trunk? 

BO3.8-3 J.M. Diamand: Foam sclerotherapy of GSV with polidocanol 3% vs 1%: a 

randomized controlled study. 36 months follow up 

BO3.8-4 A. Shimanko: Minimally invasive technologies in the treatment of the varicose 

disease 

BO3.8-5 F. Vin: Endovenous Laser treatment of Short Saphenous Vein (SSV) 

BO3.8-6 E. Burleva: The incompetent perforating veins: some aspects of hemodynamic and 

surgical treatment



BO3.8-7 R. Dremov: Combined therapy in patients with varicose veins and lower 

extremities lymphedema 

BO3.8-8 J.P. Benigni, A.Cornu-Thénard, J.F. Uhl: Efficiency of Medical Compression 

Stockings (MCS) and Venous Disorders: is pressure the only useful criteria ? 

Genevoix Free Paper Session: Venous Ulcer Treatment, Grafts (GE3.8) 

16.30-18.30 Chairperson: J. Benigni 

Moderator: P.L. Antignani 

GE3.8-1 D. De Anna: The biotechnologies in the treatment of neuro-vascular ulcers of the 

lower limbs. Cultivated autograft of skin: fibroblasts and/or cheratinocytes 

GE3.8-2 E. De Boer: Autologous cultured skin, Tiscover® for ambulant treatment of hardto-heal 

leg ulcers: a revolutionary approach 

GE3.8-3 G. Mosti: Allograft in the treatment of nonhealing skin ulcers 

GE3.8-4 S. Mancini: Leg ulcers treatment with homologous graft 

GE3.8-5 S. Mancini: Platelet gel in the treatment of distal leg ulcer 

GE3.8-6 M.Stücker: The soft-focused shock wave therapy activates the healing of long 

lasting and therapy resistant venous ulcers - results of a pilot study 

GE3.8-7 M.Simka: Air-plethysmographic prognostic factors of delayed healing of venous 

leg ulcers 

GE3.8-8 R. Lonardi: Multidisciplinary chronic leg ulcers service in Modena: data analysis 

GE3.8-9 A. Körber: Differentiated analysis of the aetiology of 30,466 patients with chronic 

leg ulcers in Germany 

GE3.8-11 M. Simka: Seasonal variations in the onset and healing rates of venous leg ulcers 

27

28 


Thursday, September 3 rd 

07.30-08.45 


K. Parsi: Interaction of Detergent Sclerosants with the coagulation system: 

an update 

M. Schadeck: discussant moderator 


A. Comerota: DVT - how to treat in daily practice? 

M. Kurtoglu: discussant moderator 


L. Kabnick: Radiofrequency and Laser Venous Ablation: 

Results and Complications 

O. Pichot: discussant moderator 


09.00-11.00 

Prince Pierre Varicose Veins (PP4.2) 

Chaiperson: M. Perrin 

Moderator: J. Barrett 

PP4.2-1 E. Rabe: Epidemiology of varicose veins 

PP4.2-2 A. Caggiati: The role of saphenous tributaries in the development of primitive 


PP4.2-3 P. Pittaluga: Tributary treatment in saphenous insufficiency - outcome after 4 

years 

PP4.2-4 A. Van Rij: Prevention of recurrent varicose veins after surgery 

PP4.2-5 F. Pannier: Outcome after endovenous laser ablation 

PP4.2-6 L. Kabnick: Laser Update: New Wavelength or New Laser Fibers? 

PP4.2-7 B. Disselhoff: Do we need SFJ ligation in endovenous procedures? 

PP4.2-8 N. Morrison: Foam sclerotherapy - the challenge of neurological symptoms 

PP4.2-9 J.L. Gillet: Physiopathology of visual disturbances occurring after 

foam sclerotherapy 

PP4.2-10 A. Frullini: New perspectives in collagen shrinking in venous insufficiency 



11.30-12.00 


Chaiperson: C. Jantet 

P. Neglen: Chronic Venous Insufficiency - Think Obstruction! 


12.00-13.00 

Prince Pierre UIP Consensus Venous Oedema and Skin Changes (PP4.4) 

Chairperson: J. Strejcek 

Moderator: I. Staelens 

PP4.4-1 J.J. Guex: Development of a questionnaire to evaluate the burden of venous 

disease on daily life 

PP4.4-2 A. Davies: Recommendations for evaluation of outcomes after treatment 

of C0s-C4 patients


PP4.4-3 A. Scuderi: UIP consensus in diagnosis and treatment of venous œdema 

PP4.4-4 A. Cornu-Thénard: UIP consensus in diagnosis and treatment of CVI related skin 

changes 


13.00-14.00 

Bosio Servier Vein Consult Project (BO4.5) 

Chairpersons: E. Rabe, J.J. Guex 

BO4.5-1 E. Rabe: Chronic venous disease: magnitude of the problem and unsolved 

questions 

BO4.5-2 J.J. Guex: An international Vein Consult Program: for what? 

BO4.5-3 A. Puskas, V. Bogachev, J.J. Guex: Description of the Vein Consult Program: 

assessment by GPs, specialists and patients 

BO4.5-5 S. Milic: Which data can we expect from the Vein Consult Program? 

13.00-15.00 

Auric Session of the German Society of Phlebology (AU4.5) 

General Assembly 

14.00-15.00 

Presentation of posters by authors DIA 47 to 61 


Discussants: M. Cazaubon, M. Patel 

THURSDAY, SEPTEMBER 3 rd 

14.00-16.00 

Prince Pierre Free Paper Session: Sclerotherapy 5: Saphenous Veins (PP4.6) 

Chairperson: J. Kuiper 

Moderator: P. Raymond-Martinbeau 

PP4.6-1 M. Sica: Ultrasound guided sclerotherapy with micro-foam: a free, practical and 

illustrated guide with DVD 

PP4.6-2 S.Vayuvegula: Long-term results of a staged sequential sclerotherapy protocol for 

the treatment of junctional reflux 

PP4.6-3 S. Reich-Schupke: A double-balloon catheter for foam-sclerotherapy of the great 

saphenous vein - critical review on preliminary results 

PP4.6-4 C. Hamel-Desnos: Foam versus liquid polidocanol in sclerotherapy of the great 

saphenous vein: a multicentre randomized controlled trial with a two-year 

follow-up 

PP4.6-5 C. Hamel-Desnos: Comparison of 1% and 3% polidocanol foam in sclerotherapy of 

the great saphenous vein: a randomized, double-blind trial with 2 year-follow-up. 

‘‘The 3/1 study’’ for the French Society of Phlebology 

PP4.6-6 M. Schadeck: Liquid or foam: which one is the best? 

PP4.6-7 F. Ferrara: Failures of sclerotherapy of the great saphenous vein, clinical 

and subclinical recurrencies 

PP4.6-8 A. Cornu-Thénard, M. Schadeck, J.F. Uhl: Sclerotherapy modalities of the GSV 

and inflammatory complications 

PP4.6-9 A. Cavezzi: Phlebectomy of varicose tributaries combined with transcatheter foam 

sclerotherapy of the saphenous vein: a randomized controlled study 

PP4.6-10 N. Shadid: Cost minimization study comparing surgery vs duplex guided foam 

sclerotherapy of varicose veins: a randomized controlled study 

29

30 



PP4.6-11 C. Hamel-Desnos: Foam sclerotherapy of saphenous veins and biological 

consequences on circulating blood. Controlled randomized study with or without 

compression stockings 

PP4.6-12 P. Van Dale: Should we still remove incompetent short saphenous vein? 

Camille Blanc Joint Symposium on Phlebolymphedema 

14.00-16.00 International Union of Phlebology & European Society of Lymphology (CB4.6) 

Chairpersons: H. Partsch, S. Michelini 

CB4.6-1 S. Michelini: Physiopathology of phlebolymphedema 

CB4.6-2 B.B. Lee: Diagnostic and therapeutical implications in truncular and extratruncular 

lympho-venous malformations 

CB4.6-3 P. Bourgeois: Nuclear medicine in Phlebolymphology 

CB4.6-4 R.J. Damstra: The treatment of large arm 

CB4.6-5 C. Lohrmann: MR- Lymphangiography 

CB4.6-6 H.G.J. Voesten: The surgical indications in Lymphedema 

CB4.6-7 C. Campisi: LVA microsurgical indications 

CB4.6-8 H. Partsch: Evidence based elastocompressure in phlebolymphology 

CB4.6-9 A. Pissas: Prevention of lymphedema: give good advices to the patients, but 

essentially to the surgeons and the radiotherapist! 

CB4.6-10 A. Leduc: European consensus on physical treatment of phlebolymphedema 

Discussion 

Apollinaire Free Paper Session: Endovenous Procedures 7 - Complications (AP4.6) 

14.00-16.00 Chairperson: JL. Gillet 

Moderator: T. Noppeney 

AP4.6-1 P. Sridhar: Postoperative pain and return to work following endovenous 

laser ablation of varicose veins 

AP4.6-2 R. Vellettaz: Complications in EVLT 

AP4.6-3 L. Kabnick: Are DVT rates higher for radiofrequency ablation of small saphenous 

veins? 

AP4.6-4 T. King: How safe and effective is high energy endovenous laser ablation? 

AP4.6-5 T. King: Can saphenous and sural nerve paresthesia be prevented during ELT? 

AP4.6-6 H. Agis: Minimization of thermally induced thrombosis of the sapheno-femoral 

junction during endothermal ablation of the great saphenous vein; safe position 

for catheter tip placement 

AP4.6-7 L. Kabnick: Endothermal heat induced thrombosis: classification, natural history 

and treatment guidelines 

AP4.6-8 S. Kaspar: Comparison between traditional and endovenous laser varicose veins 

procedure in terms of quality of life 

AP4.6-9 R.R. Van Den Bos: Complications of endovenous laser ablation: review of the 

literature and special cases 

AP4.6-10 K. Böhler: Does laser induced endothelial damage of the great saphenous vein 

extend into the saphenofemoral junction? 

Bosio Session of the American Venous Forum (BO4.6) 

14.00-16.00 Chairperson: J. Lohr 

BO4.6-1 M. Vasquez: Venous Clinical Severity Scoring Update 

BO4.6-3 M. Lohr: Speaking the same language - venous ultrasound controversies 

BO4.6-4 M. Meissner: Pelvic Venous Congestion 

BO4.6-5 B. Eklöf: Renaissance for Early Thrombus Removal in Acute Iliofemoral DVT: 

Role of Mechanical and Surgical Thrombectomy 

BO4.6-6 J. Comerota: Role of Lytics 

BO4.6-7 S. Raju: Modern concepts in the pathophysiology of chronic venous disease 

BO4.6-8 M. Dalsing: Options for Venous Valve Repair / Replacement


Genevoix Short Free Paper Session II (GE4.6) 

14.00-16.00 Chairperson: L. Schimmelpfenning 

Moderator: A. Gasparis 

GE4.6-1 E. Bernardini: Echo-sclerosis hemodynamic conservative (ESEC). A new method 

for venous insufficiency treatment 

GE4.6-2 K. Hartmann: Reversible neurological deficit after foam sclerotherapy 

GE4.6-3 U. Alonzo: Sclero-mousse in great saphenous vein insufficiency; long term results 

GE4.6-4 M. Valsamis: Soft sclerotherapy of the hand veins 

GE4.6-5 S. Belentsov: Ultrasound-guided foam sclerotherapy: which main conclusions to 

be drawn from the experience of 2440 procedures. Short-term results and threeyear 

follow up 

GE4.6-6 A. Hamahata: Outcomes of ultrasound-guided foam sclerotherapy for varicose 

veins of the lower extremities - single center experience 

GE4.6-7 J. Diez: Pathological anatomy of the venous wall after treatment with endoluminal 

laser. Immediate and thirty days after surgery observations 

GE4.6-8 M. Perrin: Michel Perrin for the transatlantic interdisciplinary group: the 

updated terminology of chronic venous disorders: the vein-term transatlantic 

interdisciplinary consensus document 

GE4.6-9 J. Benigni: Compression bandages influence of techniques of use on their clinical 

efficiency and tolerance 

GE4.6-10 J. Benigni: Friction index of medical compression stockings 

GE4.6-11 J. Delic: Link between etiological aspects of veins thrombosis and clinic image of 

the disease 

GE4.6-12 E. Bobrovsky: Ulcers healing and platelet growing factor 

GE4.6-13 M.Simka: Giant leg ulcers: are they actually venous ones? 

GE4.6-14 K.Kikuchi: Practical way to compare and document outcome on leg vein lesions 

treatment 

GE4.6-15 R. Garay: Antioxidant/anti-inflammatory effects of calcium dobesilate (doxiumR) in 

human varicose veins 

GE4.6-16 J. Delic: Home health care in angiology: practice and evidence based 

recommendations 

GE4.6-18 P. Molski: Manual lymphatic drainage improves the quality of life in patients with 

chronic venous disorders 

GE4.6-19 P. Bhaskaran: Electrolyte balance in pulsatile and non-pulsatile patients 

undergoing coronary artery bypass graft 

GE4.6-20 S. Sapelkin: Regionary venous renal hyperthension - diagnostic, treatment tactic 

GE4.6-21 V. Ciubotaru: Varices’ ambulatory non-stripping surgical therapy (VANST) 

GE4.6-22 Z. Böhm: Minisurgical concept in the treatment of varicose veins (preserve of the 

saphenous vein - miniphlebectomy) 



16.30-18.30 

Prince Pierre Free Paper Session: Venous Diagnosis 2 (PP4.7) 

Chairperson: F. Vin 

Moderator: V. Wienert 

PP4.7-1 J. Leal Monedero: The Nutcracker Syndrome 

PP4.7-2 A. Kornberg: Diagnosis and treatment of venous pelvic. Syndrome congestion 

pelvic vulvar varicose vein 

PP4.7-3 A. Sanchez-Galan: Left renal vein compression syndrome: diagnosis with duplex 

ultrasound 

PP4.7-4 S. Katorkin: Varicose pelvic vein disease: diagnosis and therapy 

PP4.7-5 O. Hartung: Risk factors of technical failure during endovascular treatment of 

post-thrombotic femoro-iliac venous obstructive lesions 

31

32 



PP4.7-6 M. Kazakmurzaev: Reflux of the proximal femoral vein valves can be corrected by 

an angioscopically directed vedensky spiral 

PP4.7-7 N. Morrison: Prevalence of reflux in the great saphenous vein as a function 

of diameter 

PP4.7-8 S. Ray: The prevalence of bilateral saphenous reflux and abnormal venous refilling 

times in patients with varicose veins 

PP4.7-9 T. Spina: Distribution of venous reflux in CVI of the lower limbs, by duplex 

investigation 

PP4.7-10 F. Vega.: A method for the diagnosis and record of venous insufficiency with 

pocket doppler´s use 

PP4.7-11 M. Markovic: The role of ultrasonography in surgical treatment of acute 

thrombophlebitis of great saphenous vein 

PP4.7-12 T. Spina: The value of doppler venous pressure index in the diagnosis of chronic 

venous insufficiency of the lower limbs 

Camille Blanc BSN Jobst Symposium 

16.30-18.30 Patient compliance in compression therapy - Does it really matter? (CB4. 7) 

Chairperson: E. Rabe 

CB4.7-1 E. Rabe: What does Compliance mean? 

CB4.7-2 F. Pannier: Further results of the Bonn Vein Study on compliance of CVI patients 

CB4.7-3 E. Rabe: Results of a prospective and retrospective research on compliance of 

CVI patients in Germany 

CB4.7-4 C. Moffat: Compliance issues of venous ulcer patients 

CB4.7-5 S. Vignes: Importance of compliance in management of arm lymphedema after 

breast cancer treatment 

CB4.7-6 JP. Benigni: Efficiency of low pressure Medical Compression Stockings (MCS) on 

venous symptoms: a micro-massage effect? 

Apollinaire Free Paper Session: Thromboembolic diseases 1 (AP4.7) 

16.30-18.30 Chairperson: J. Lohr 

Moderator: M. Kurtoglu 

AP4.7-1 M. Kurtoglu: Venous thromboembolism prophylaxis methods in the trauma and 

emergency surgery intensive care unit patients 

AP4.7-2 J. Scurr: Travellers’ thrombosis: airlines still not giving passengers the wright advice! 

AP4.7-3 C. Jeanneret-Gris: Deep venous thrombosis investigated with ultrasound 

contrast agent 

AP4.7-4 R. Bauersachs: Gender difference in clinical presentation of deep vein thrombosis 

AP4.7-5 S. Schulz: Deep venous thrombosis and varicosity 

AP4.7-6 T. Yamaki: Presence of lower limb deep vein thrombosis and prognosis in patients 

with symptomatic pulmonary embolism 

AP4.7-7 A. Tucker: Blood flow increase via a novel method of electrical nerve stimulation 

in the lower leg is suitable for DVT prevention 

AP4.7-8 A. Gasparis: Prospective determination of candidates for pharmacomechanical 

thrombolysis 

AP4.7-9 R. Bauersachs: Safety and efficacy of low-molecular-weight heparin (dalteparin) 

in pregnant women at increased risk of venous thromboembolism: 

a prospective stratified multicentre trial 

AP4.7-10 J. Avram: Superficial thrombophlebitis - complications and treatment 

AP4.7-11 Lefeng Qu: Diagnosis and treatment of deep venous thrombosis caused by 

pelvic tumor 

AP4.7-12 J. Ragg: Five Modalities for Mini-Thrombectomy of epifascial veins


Bosio Session of the American College of Phlebology ( BO4. 7) 

16.30-18.30 


BO4.7-1 J. Mauriello, E.J. Sanchez, J. White, W. Schroedter, B. White: Preliminary results of 

low energy density laser ablation treatment of incompetent truncal veins 

BO4.7-2 J. A. Zygmunt Jr: Understanding Duplex Venous Ultrasound for Phlebology 

BO4.7-3 L. Kabnick: A new phlebectomy algorithm: first, second, third 

BO4.7-4 S. Zimmet: American Board of Phlebology: Certification Examination 

BO4.7-5 T. Morrison: Compression therapy after phlebologic interventions: How Much? 

How Long? How High? A United States Perspective 

BO4.7-6 P. Raymond-Martimbeau: Effectiveness of single injection of sodium tetradecyl 

sulfate on predicting outcomes following ultrasound foam sclerotherapy using 

ultrasound scoring system 

BO4.7-7 D. Neuhardt: Differences in saphenous vein reflux detection according to patient 

positioning 

BO4.7-8 N. Morrison: The complementary roles of surgery, endovenous thermal ablation, 

and foam sclerotherapy in the treatment of chronic venous insufficiency - 

the U.S. perspective 

BO4.7-9 J. Bergan: Venous Ulcers: How to treat them without surgery 

Genevoix Short Free Paper Session III (GE4.7) 

16.30-18.30 Chairpersons: N. Rosli 

Moderator: P. Neglen 

GE4.7-1 T. Yasugi: A case of combined therapy for the arteriovenous malformation in 

the tigh - surgery and interventional radiology 

GE4.7-2 N. Morrison: Endovenous thermal ablation of patient with klippel-trenaunay 

syndrome 

GE4.7-3 P. Chapman-Smith: Endovenous laser ablation with 1320nm of an arm venous 

malformation 

GE4.7-4 L. Chernukha: Complex treatment of venous and arterio-venous congenital 

vascular malformations of the lower limbs 

GE4.7-5 L. Kanina: Treatment of patients suffering from dysplasia of superficial vein upper 

and lower extremities 

GE4.7-7 E. Tsolaki: The C.E.A.P.-L classification for lymphedemas of the limbs 

Our experience 

GE4.7-8 D-A.A. Lamprou: Relationship between interface pressure and operative volume 

reduction in patients with lymphedema of the extremities 

GE4.7-9 E. Bobrovsky: Lymphangiogenesis in the rabbit ear using stem cells from 

peripherical blood under stimulation by G_CSF (filgrastim) 

GE4.7-10 R. Belmonte: Efficacy of sound waves in the upper limb lymphedema treatment 

GE4.7-11 M. Ruzicka: Treatment of cystic retroperitoneal lymphangioma 

GE4.7-12 A. Brigic: Targets and a robust delivery model are required to stop hospitalized 

patients being put at risk from venousthromboembolism 

GE4.7-13 M. Schul: Superficial thrombophlebitis: a case report with a life threatening 

complication 

GE4.7-14 J. Delic: Polycithemia Rubra Vera (PRV) – venous thrombosis risk factors 

GE4.7-15 E. Burleva: Deep venous thrombosis: an overview of hospital treatment 

GE4.7-16 G. Arpaia: Risk of DVT in wheelchair-bound or bedridden patients with multiple 

sclerosis: a prospective study 

GE4.7-18 L. Zhang: Four-dimensional computed tomography perfusion imaging for 

DVT/PATE application 

33

34 


Friday, September 4 th 

07.30-08.45 


A. Cavezzi: Foam Sclerotherapy and phlebectomy - what are the best strategies? 

T. Yamaki: discussant moderator 


P. Neglen, S. Raju: Ilio-femoral obstruction - how to treat the disease? 

K. Burnand: discussant moderator 


E. Rabe: US Guided foam sclerotherapy: references and practical applications 

F. Vin: discussant moderator 


09.00-11.00 

Prince Pierre Deep Venous Insufficiency (PP5.2) 

Chaiperson: O. Maleti 

Moderator: N. Labropoulos 

PP5.2-1 H. Gerlach: Three year follow up of patients with DVT monitored in the TULIPA 

registry 

PP5.2-2 A.Van Rij: The time sequence of the development of axial deep reflux following 

lower limb DVT - a prospective study over 5 years 

PP5.2-3 S. Raju: Iliac vein stenting - indications and long term results 

PP5.2-4 O. Hartung: Long-term results of stenting for femoro-iliac veins obstructive lesions 

PP5.2-5 H. Partsch: Prevention of postthrombotic syndrome with compression treatment - 

evidence from comparative studies 

PP5.2-6 N. Labropoulos: Impact of iliofemoral thrombosis on the development of 

postthrombotic syndrome 

PP5.2-7 O. Maleti: Neovalve in postthrombotic syndrome - long term results 

PP5.2-8 M. Dalsing: The future of artificial venous valves 



11.30-12.00 


Chaiperson: C. Allegra 

B.B. Lee: Embryology of the venous network 


12.00-13.00 

Prince Pierre UIP Consensus Venous malformation & Lymphoedema (PP5.4) 

Chairpersons: B.B. Lee, N. Piller 

PP5.4-1 B.B. Lee: Consensus on Venous Malformation 

PP5.4-2 B.B. Lee: Consensus on Primary lymphœdema, lymphatic malformation 

PP5.4-3 N. Piller: Secondary phlebo-lymphoedema: definition, diagnosis and treatment 

Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)

FRIDAY, SEPTEMBER 4 th 


14.00-16.00 

Prince Pierre Free Paper Session: Endovenous Procedures 8 / Treatment 

Sclerotherapy 6 - Safety (PP5.6) 

Chairperson: K. Myers 

Moderator: J. Mauriello 

PP5.6-1 L. Corcos: Endovenous 808 nm diode laser ablation of varicose collaterals. 

Clinical and instrumental results after six years 

PP5.6-2 V. Barucchello: Endovenous 808 nm diode laser ablation of incompetent 

perforators. Clinical and instrumental results after six years 

PP5.6-3 L. Corcos: Laser-assisted surgery of hemorrhoids by 808 nm diode laser 

PP5.6-4 D. Pontello: Duplex and histological changes of the great saphenous vein in twelve 

months after 808 nm diode laser irradiation. Further details 

PP5.6-5 B. Elezi: Endovenous 808 nm diode laser ablation of incompetent saphenous 

veins. Clinical and duplex results after six years 

PP5.6-6 J. Rush: Endovenous microfoam ablation in patients with migraine headache 

with and without Right-to-Left (R-L) cardiac shunt 

PP5.6-7 J. Rush: Lack of concordance between presence of Right-to-Left shunt and 

detection of middle cerebral artery emboli during endovenous microfoam 

ablation 

PP5.6-8 N. Morrison: Testing of maneuvers for prevention of foam migration during 

ultrasound-guided foam sclerotherapy 

PP5.6-9 D. Neuhardt: Correlation of cerebral emboli, symptoms, and volume injected 

during ultrasound guided foam sclerotherapy 

PP5.6-10 N. Morrison: Safety of ultrasound-guided foam sclerotherapy with physiological 

CO2-O2 gas 

PP5.6-11 D. Neuhardt: Cerebral emboli comparison detected by transcranial doppler during 

ultrasound- guided sclerotherapy using CO2/02-based foam or air-based foam 

PP5.6-12 M.V .Rubia: Safety and efficacy endovenous chemical ablation with polidocanol 

microfoam in elderly patients with chronic venous insufficiency 

Camille Blanc Sigvaris Symposium: Medical Compression Stockings (MCS) for venous disorders 

and diseases - original studies presented by the authors (CB5.6) 

Moderators: E. Rabe, H. Partsch, M. Perrin 

1 st Part: MCS for venous disorders 

Chaipersons : E.Rabe, M.Perrin 

CB5.6-1 E. Rabe: Use of MCS in the general population - Data from the Bonn Vein Study 

CB5.6-2 P. Kern: MCS after interventions on varicose veins 

CB5.6-3 F. Amsler: Meta-analysis of MCS for patients with venous disorders 

CB5.6-4 W. Blättler: MCS for occasional leg symptoms 

2 nd Part: MCS for venous ulcers and other severe venous diseases 

Chairpersons: J.J. Guex, H. Partsch 

CB5.6-5 E.O. Brizzio: Moderate strength MCS for the treatment of recalcitrant venous 

ulcers are not inferior to mutlilayer short-stretch bandages 

CB5.6-6 F. Mariani: RCT comparing a double stocking system (Ulcer X) with bandages 

CB5.6-7 F. Amsler: Meta-analysis of studies comparing MCS with bandages 

CB5.6-8 W. Blättler: Analysis of risk factors relevant to choose compression therapy for 

venous ulcers 

35

36 



CB5.6-13 S. Wagner: Round knitted MCS are not inferior to Flatt-knitted MCS for 

the treatment of stable lymphedema 

CB5.6-9 J.J. Guex: Experiences by doctors and patients of MCS 20-36mmHg 

CB5.6-10 D. Rastel: How to improve compliance of compression therapy (20-36 mmhg)? 

- biomechanics of MCS 

- survey on MCS compliance 

CB5.6-11 P. Humbert: Interactions of skin and MCS during donning process 

CB5.6-12 E. Le Floch: Survey on MCS compliance 

Apollinaire Free Paper Session: Varicose Veins-Miscelleanous (AP5.6) 

14.00-16.00 Chairperson: C. Pereira Alves 

Moderator: A.C. Benhamou 

AP5.6-2 Y. Herouy: The role of tight junctions in venous disease 

AP5.6-3 I. Bihari: Laser-Doppler Examination of Corona Phlebectatica Paraplantaris 

AP5.6-4 F. Allaert: Socioeconomic consequences of the phlebotonic drug 

de-reimbursement 

AP5.6-5 Y. Novikova: Pharmacogenomics: new reality of modern phlebology 

AP5.6-6 P. Carpentier: Evaluation of balneotherapy associated with patient education in 

patients with advanced chronic venous insufficiency: a randomized controlled 

trial in the spa Resort of la Léchère 

AP5.6-7 J.M. Chardenneau: Study on the effectiveness of medical treatment based on IRFA 

on legs cellulitis 

AP5.6-8 C. Simkin: Transdermal cryolaser and cryo sclerotherapy in the treatment of 

telangiectasies and reticular veins 

AP5.6-9 J. Lopez D´Ambola: Transdermal laser theraphy for the superficial venous 

insufficiency 

AP5.6-11 E. Rabe: Calcium dobesilate in patients suffering from chronic venous 

insufficiency. A double-blind, placebo-controlled, clinical trial 

Bosio Session of the European Venous Forum (BO5.6) 

14.00-16.00 Workshop on updating International guidelines on the prevention 

of venous thromboembolism 

Genevoix Free paper session: Venous Surgery 2 (GE5.6) 

14.00-16.00 Chairperson: O. Hartung 

Moderator: H. Fronek 

GE5.6-1 S. Camilli: The external stretching valvuloplasty: a new technique for venous valve 

repair 

GE5.6-2 S. Chastanet: Surgical treatment of varices with tumescent local anesthesia 

heavily diluted in bicarbonate: “the gentle surgery” 

GE5.6-3 P. Pittaluga: Value of the preservation of the saphenous vein for the surgical 

treatment of varices in young nullipara patients 

GE5.6-4 S. Chastanet: The effects of isolated phlebectomy on reflux and diameter of the 

great saphenous vein : a prospective study 

GE5.6-5 M. Lefebvre-Vilardebo: Saphenectomy without crossectomy, an easy and safe 

alternative solution to endovenous techniques 

GE5.6-6 P. Casoni: Is still crossectomy the first obliged step in varicose vein surgery? 

6 yrs follow up in a randomized study in 124 legs without inguinal dissection 

GE5.6-7 S. Gianesini: High ligation in chronic venous disease of the lower limbs: an 

unavoidable surgical approach? 

GE5.6-8 A. Scuderi: A strategy of varicose syndrome management based in haemodynamic 

concepts


GE5.6-9 M. Lefebvre-Vilardebo: Varicose great saphenous vein: no need for treating 50% 

junctions. From a series of 790 legs 

GE5.6-10 G. Genovese: Role of the stick of sapheno-femoral im post LEV recurrence 

or stripping 



16.30-18.30 

Prince Pierre Free Paper Session: Venous Ulcer Treatment II (PP5.7) 

Chairperson: G. Mosti 

Moderator: O. Nelzen 

PP5.7-1 D. Milic: Multi-layer bandaging system with Tubulcus® in the treatment of venous 

leg ulcers 

PP5.7-2 G. Mosti: Elastic stockings and ulcer treatment: what about pressure and 

stiffness? 

PP5.7-3 P. Lloret: Treatment of 180 venous ulcers with microfoam sclerotherapy 

PP5.7-4 L. Hnatek: Radiofrequency-induced thermotherapy (RFITT) and ultrasound guided 

foam sclerotherapy - a comparison study for the treatment of chronic venous 

ulcers 

PP5.7-5 Z.Maksimovic: The significance of CEAP classification for choice of surgical 

method intreatment of venous ulcers 

PP5.7-6 B. Palmieri: Autologous stem cells injection in diabetic foot ulcer: an experimental 

and clinical study 

PP5.7-7 G. Daeschlein: MRSA- and infection-management of chronic wounds in 

dermatology 

PP5.7-8 A. Körber: Clinical investigation on Panton-Valentin Leukocidin (PVL)-positive 

staphylococcus aureus isolates in patients with chronic wounds 

PP5.7-9 A. Körber: Gram negative bacteria on the advance: results of a comparative 

clinical investigation in chronic leg ulcers about 5 years 

PP5.7-10 J. Dissemond: First results of a comparative analysis of 50 patients with chronic 

leg ulcers with a new technique (Essen Rotary) for bacterial smears 

PP5.7-11 S. Reich-Schupke : Practicable patch test program for patients with leg ulcers with 

special reference to products of modern wound care - results of a prospective 

study in correlation with literature 

PP5.7-12 B. Palmieri: Skin cancer following a long standing lower leg ulcer 

Apollinaire Short Free Paper session IV (AP5.7) 

Chairperson: M. Marshall 

Moderator: D. Neuhardt 

AP5.7-1 K. Wasilewski: Incompetent perforator vein ablation by endovenous laser 

treatment with 1470 nm laser - first report in the Middle East 

AP5.7-4 V.M. Canata: Endolaser venous system in Paraguay 

AP5.7-5 V. Patel: The management of combined greater and small saphenous vein reflux 

using endovenous laser ablation 

AP5.7-6 V. Brown: Single puncture technique for laser ablation and foam sclerotherapy to 

the great saphenous vein 

AP5.7-7 V. Brown: Patient-reported outcomes following simultaneous endovascular laser 

ablation of the small and great saphenous veins 

AP5.7-8 V. Patel: Endovenous laser ablation of the greater saphenous vein: early 

experience using a low energy radial fibre (ELVES) 

AP5.7-9 H. Sugawara: Transient thrombocytosis after endovenous laser treatment for 

primary lower extremity varicose vein 

37

38 



AP5.7-10 M. Kazakmurzaev: Prophylaxis of minor complications after endovenous laser 

treatment of primary varicose veins 

AP5.7-11 G. Botta: Recurrent varicose veins after endovenous laser treatment 

AP5.7-12 V. Ivan: The great saphenous vein crosse versus the saphenofemoral junction 

AP5.7-13 C. Lebard: Calculation of energy in segmental ablation of greater saphenous vein 

by radiofrequency 

AP5.7-14 M. Hirokawa: 1470nm endovenous laser treatment of the great saphenous vein: 

more than 5-month follow-up 

AP5.7-15 C. Hayes: Successful treatment of unilateral restless legs syndrome and 

superficial venous insufficiency with endovenous laser ablation and 

ultrasound-guided chemoablation 

AP5.7-16 A. Sanchez-Galan: Is the thrombosis of the Internal Saphenous Vein (ISV) 

post- endovenous laser treatment (EVLT) a predictive factor for the technique 

failure? 

AP5.7-17 J. Titon: Laser treatment of the telangiectasias of the feet, (360 patients treated 

during 4 years) 

AP5.7-18 V. Canata: Laser treatment of venous leg ulcer in Paraguay 

AP5.7-19 J. Hovorka: Report of improvement in hemodynamic dysfunction and disability 

secondary to CVD with Multiple Tributary Vein Ablation (MTVA) in 2 patients: 

correction of chronic obstruction (APG outflow fraction with superficial occlusion) 

AP5.7-20 S. IIda: Stripping under tumescent local anesthesia using ultrasound scanning 

during operation 

AP5.7-21 G. Makhatilov: Does preventive external correction of the GSV ostial valve change 

the course of varicose disease at healthy SFJ PTS? 

AP5.7-22 T. De Bo: The use of a new endovenous laser device: results of the 1500 nm laser 

Bosio Session of the Italian College of Phlebology 

16.30-18.30 Endovascular treatment of Varicose Veins (BO5.7) 

Chairpersons: C. Allegra, E. Rabe 

BO 5.7-2 E. Rabe: Endovenous procedures - the German experience 

BO5.7-3 V. Gasbarro: Radiofrequency indication and usefulness 

BO5.7-4 L. Tessari: Scleromousse as first choice 

BO5.7-5 M. Sica: Scleromousse: a technique in progress? 

BO5.7-6 P.L. Antignani: Thromboembolic complications: is it a problem? 

Genevoix Thromboembolic disease II (GE5.7) 

16.30-18.30 Chairperson: R. Simkin 

Modertor: M. De Maeseneer 

GE5.7-1 H. Kiesewetter: Thrombosis prophylaxis in endovenous interventions 

GE5.7-3 D. Jadranin: Venous thrombectomy vs. conventional anticoagulant treatment of 

iliofemoral venous thrombosis-early results and 6 months follow up 

GE5.7-4 F. Vin: Etiological diagnosis of 70 patients with deep vein thrombosis of lower 

limbs 

GE5.7-5 R.Kreidy: Contribution of factor V R 506 Q - leiden, prothrombin G 20210 A and 

MTHFR C 677 T mutation to the genetic susceptibility of deep vein thrombosis 

of lower extremities. Is screening for factor V H 1299 R and MTHFR A 1298 C 

justified? 

GE5.7-6 Y. Novikova: Determination of the haemostasis system’s genes: from standard to 

personalized medicine 

GE5.7-7 S. Michelini: Hyperhomocysteinemia and venous thrombosis: our experience


GE5.7-8 H. Gerlach: Adherence to guidelines on current practice in diagnostic work-up of 

patients with suspicion of DVT 

GE5.7-9 J. Duque Botero: Prevalence of sticky platelets in a Colombian family, clinical 

implications, possible hereditable pattern and study of platelet receptors. 

Preliminary results 

GE5.7-10 F. Casals Sole: A normal D-dimer value, measured by a high sensitivity assay, 

rule out a suspected venous thromboembolism episode independently of pretest 

clinical probability 

GE5.7-11 W. Koeyers: Phlebography of the lower limb: revival of a dying art 

18.30 

Prince Pierre Closing remarks 


39

40 

LIST OF ACCEPTED POSTERS 

Posters presented on Monday, August 31 st from 14.00 to 15.00 (Diaghilev area) 

DIA1 HISTORY AND CURRENT STATUS OF THE KOREAN SOCIETY OF PHLEBOLOGY - D. Kim 

DIA2 EFFECTIVENESS OF WEIGHT LOSS ON THE EVOLUTION OF CHRONIC VENOUS INSUFFICIENCY (CVI) AFTER BARIATRIC SURGERY IN 

OBESE PATIENTS - J. Benigni 

DIA3 HUNGARIAN NAMES IN THE PHLEBO-LYMPHATIC CLINICAL RESEARCH - I. Bihari 

DIA4 LESS RECURRENT VARICOSIS OF THE SAPHENOFEMORAL JUNCTION BY PERFORMING MODIFIED CONTINUOUS SUTURE OF THE 

FEMORAL VEIN? - M. Broermann 

DIA5 LASER VEIN THERAPY ASSOCIATED TO SCLEROTHERAPY OF ISOLATED TELANGIECTASIAS. PERSONAL PROSPECTIVE EVALUATION 

C. Burtica 

DIA6 FREQUENCY OF INTIMA-MEDIA THICKNESS INCREASE AND OF ATHEROSCLEROTIC PLAQUES IN ASYMPTOMATIC PATIENTS 

M. Cazaubon 

DIA7 ENDOVENOUS LASER TREATMENT (EVLA) OF GASTROCNEMIUS VEIN REFLUX WITH 1320NM - 2 CASE REPORTS - P. Chapman-Smith 

DIA8 CONTEMPORARY METHODS OF SURGICAL TREATMENT OF VARICOSE DISEASE IN LOWER LIMBS VEINS - A.I. Chernookov 

DIA9 STEP BY STEP OF ENDOVASCULAR LASER PROCEDURE FOR TREATING VARICOSE VEINS: OUR EXPERIENCE - L. Narvaes 

DIA10 LAPAROSCOPIC VARICOCELECTOMY - A. Cotirlet 

DIA11 PYODERMA GANGRENOSUM-RARE COMPLICATION OF SCLEROTHERAPY - E. De Felice 

DIA12 THE “PUSH-UP”: AN ORIGINAL TECHNIQUE FOR THE SURGICAL CORRECTION OF RECTO-HAEMORRHOIDAL PROLAPSE. PERSONAL 

EXPERIENCE - F. Di Benedetto 

DIA13 LEG ULCERS IN THE PATIENT WITH KLIPPEL-TRENAUNAY SYNDROME - A CASE REPORT - K. Djukic 

DIA14 AMBULATORY TREATMENT OF VARICOUS VEINS – POSSIBILITIES AND LIMITS - C. Duta 

DIA15 LATE COMPLICATIONS THE SEQUEL OF DEEP VENOUS THROMBOSES GROZDINSKI L., M. STANKEV, A. DRAMOV NATIONAL HOSPITAL 

OF CARDIOLOGY, DEPARTMENT OF VASCULAR SURGERY AND ANGIOLOGY, SOFIA, BULGARIA - L. Grozdinski 

DIA16 THE TRUE CAUSE OF VARICOSE VEINS IS CHAIR-SITTING - M. Oswald 

Posters presented on Tuesday, September 1 st from 14.00 to 15.00 (Diaghilev area) 

DIA17 THE A OF CEAP: IMAGING OF VEIN WALLS - T. Alekperova 

DIA18 EVALUATION OF A NOVEL TWO LAYER COMPRESSION STOCKING SYSTEM IN THE TREATMENT OF VENOUS LEG ULCERS 

J. Benigni 

DIA19 RECURRENCES OF THE SAPHENOFEMORAL JUNCTION DUE TO AN INCOMPENTENT PERSISTING SUPERFICIAL EPIGASTRIC VEIN 

M. Broermann 

DIA20 TWO CASES OF THE VENOUS ANEURYSMAL DISEASE, TRUE AND PSEUDOANEURYSM OF EXTREMITY SUPERFICIAL VEINS 

I. Jung 

DIA21 ENDOVENOUS 980-NM LASER TREATMENT OF SMALL SAPHENOUS VEINS: HOW MUCH ENERGY DO WE NEED? 

SH. Kang 

DIA22 HISTOMORFOLOGY OF CALF MUSCLES AT PATIENTS WITH PRIMARY CHRONIC VENOUS INSUFICIENCY BEFORE AND AFTER 

SURGERY 

A. Kasparov 

DIA23 RELATIONSHIP BETWEEN THERMAL EFFECT AND CARBON CAP FORMED AT THE END OF LASER FIBER FOR 810NM EVLT 

PROCEDURE 

M. Kawada 

DIA24 MASSIVV - MEN WITH ABUNDANCE SEXUAL STEROID HORMONES IN VARICOSE VEINS. 

M. Kendler 

DIA25 EXTERNAL BANDING VALVULOPLASTY FOR INCOMPETENCE OF THE GREAT SAPHENOUS VEIN: A 10-YEAR RESULTS 

D. Kim 

DIA26 ENDOVENOUS LASER TREATMENT (EVLT) OF VARICOSE VEINS - S. Kirgizbayev 

DIA27 PREOPERATIVE COLOR DUPLEX ULTRASOUND IN VARICOSE VEIN SURGERY - I. Kostov 

DIA28 ENDOVENOUS LASER ABLATION FOR COSMETIC TREATMENT OF SUPERFICIAL VEINS OF THE FACE - L. Narvaes 

DIA29 ENDOVENOUS LASER TREATMENT FOR RECURRENT VARICOSE VEINS AFTER SAPHENO-FEMORAL JUNCTION LIGATION 

N. Kurihara 

DIA30 VNUS SURGERY. FIRST EXPIRIENCE OF 30 PROCEDURS - O. Loginov 

DIA31 MINIINVASIONAL TREATMENT OF CHRONIC VENOUS INSUFFICIENCY - N. Salimzhanov 

Posters presented on Wednesday, September 2 nd from 14.00 to 15.00 (Diaghilev area) 

DIA32 SMALL SAPHENOUS VEIN TREATED BY ULTRASOUND GUIDED FOAM SCLEROTHERAPY - S. Kang 

DIA33 CHRONIC VENOUS DISEASE: PHARMACOTHERAPY WITH RED VINE LEAF EXTRACT - T. Alekperova 

DIA34 PODOCONIOSIS: A SPECIAL FORM OF LYMPHOEDEMA - M. Mooijj 

DIA35 NARROWING OF SUPERFICIAL AND DEEP VEINS BY A READY-TO-WEAR COMPRESSION DEVICE DEMONSTRATED BY MAGNETIC 

RESONANCE IMAGING - G. Mosti 

DIA36 ELASTIC COMPRESSION STOCKING AFTER ENDOVENOUS LASER ABLATION OF THE GREAT SAPHENOUS VEIN - L. Narvaes 

DIA37 NERVOUS RELATIONSHIPS OF THE SHORT SAPHENOUS VEIN - J. Uhl 

DIA38 ASSOCIATION OF CROSECTOMY AND FOAM SCLEROTHERAPY IN THE TREATMENT OF VENOUS ULCERATIONS AT ELDERLY 

PATIENTS 

M. Kowalski

DIA39 TREATMENT OF VENOUS ULCERS WITH CRONOCOL IMPLANTS – ANALYSIS OF 10 CASES - C. Costa Almeida 

DIA40 UNDERSTANDING OF DVT IS SUPERIOR TO KNOWLEDGE ABOUT IT - M. Oswald 

DIA41 MANAGEMENT OF ISOLATED CALF DEEP VEIN THROMBOSIS - S. Ota 

DIA42 BIOMEDICAL ENGINEER AND PHLEBOLOGIST: A MIDSHIP FRAME - P. Van Dale 

DIA43 SUGAR AND HONEY: CHEAP MEDICATIONS FOR THE VENOUS ULCER - F. Passariello 

DIA44 THE INCIDENCE OF MALIGNANT DISEASES AMONG PATIENTS WITH DEEP VEIN THROMBOSIS OF LOWER EXTREMITY - D. Milic 

DIA45 SEVERE DRUG-INDUCED SKIN REACTION AFTER SCLEROTHERAPY - A. Reichelt 

DIA46 LASER THERAPY IN TREATMENT OF ANGIOPATHY OF LOW EXTREMITIES OF CHRONIC VENOUS INSUFFICIENCY - N. Salimzhanov 

Posters presented on Thursday, September 3 rd from 14.00 to 15.00 (Diaghilev area) 

DIA47 PHLEBOSCLEROSING TREATMENT OF VARICOSE DISEASE USING THE «FOAM-FORM» TECHNIQUE - N. Salimzhanov 

DIA48 THE GRAPH CLASSIFICATION FOR THE VENOUS SYSTEM OF THE LOWER LIMBS - F. Passariello 

DIA50 SURGICAL INTERVENTIONS OF RECURRENCES OF THE SAPHENOFEMORAL JUNCTION IN TUMESCENT LOCAL ANAESTHESIA 

S. Schattenkirchner 

DIA51 BILATERAL ILIOFEMORAL THROMBOSIS IN 19-YEAR-OLD FEMALE WITH ABSENCE OF SUPRARENAL SEGMENT OF INFERIOR VENA 

CAVA AND HEREDITARY THROMBOPHILIA - CASE REPORT - M. Sebo 

DIA52 HYPOTHETICAL CELLULAR AND MOLECULAR MECHANISMS OF THE DEVELOPMENT OF A VENOUS LEG ULCER - M. Simka 

DIA53 ASSESSMENT OF THE QUALITY OF LIFE IN WOMEN WITH VENOUS DISEASE - C. Taïeb 

DIA54 NOBLE METHOD FOR GREAT SAPHENOUS VEIN TRUNK SCLEROTHERAPY UNDER BALLOON OCCLUSION AT SAPHENO - FEMORAL 

JUNCTION - ITS SAFETY AND EARLY RESULTS - H. Tashiro 

DIA55 SARCOIDOSIS MIMIKING THE LEG ULCERS IN THE PATIENT WITH CHRONIC VENOUS INSUFFICIENCY - A CASE REPORT 

O. Tomanovic Andonovic 

DIA56 EARLY RESULT OF RHEOLYTIC THROMBECTOMY IN PATIENTS WITH PROXIMAL - A. Tsuji 

DIA57 ENDOVENOUS ABLATION OF THE GREAT SAPHENOUS VEIN WITH LASER 980NM AND 1470NM COMPARING WITH CONVENCIONAL 

SURGERY IN PATIENTS WITH VARICOSE VEINS: SHORT TERM RESULTS - L. Narvaes 1 

DIA58 THE FOOT VENOUS PUMP : ANATOMY AND PHYSIOLOGY - J. Uhl 

DIA59 ADVANCE PHLEBOLOGY TREATMENT - 5 YEARS OWN EXPERIENCE - K. Wasilewski 

DIA60 COST-EFFECTIVE-TRAINING DEVICE FOR MICRO FOAM ULTRASOUND-GUIDED SCLEROTHERAPY [UGS] FOR VARICOSE VEIN 

TREATMENT 

J. Wulf 

DIA61 AMBULATORY PHLEBECTOMY IN THE TREATMENT OF VARICOSE VEINS - S. Zivic 

LIST OF ACCEPTED VIDEOS 

which are running continously every day from 9.00 to 18.00 

in Diaghilev Exhibition area 

VIDEO 1 CORRELATIONS BETWEEN INTERFACE PRESSURE MEASUREMENTS AND A CT SCAN WITH 3D RECONSTRUCTION UNDER SPECIFIC 

ECCENTRIC COMPRESSION AT THE THIGH LEVEL 

J. Benigni 

VIDEO 2 SEPS - THE WAY WE TREAT INCOMPETENT PERFORATORS 

C. Costa Almeida 

VIDEO 3 RETICULAR VEINS ON THE FACE: EXPERIENCE OF SEVEN YEARS ON LASER TREATMENT 

F.H. Duarte 

VIDEO 4 3D VIRTUAL TRIP IN THE VENOUS SYSTEM 

J. Uhl 

VIDEO 5 VIDEO COMPARISON OF IN VIVO AND IN VITRO PATTERNS OF FOAM SCLEROSANT DISTRIBUTION 

J. Ragg 

VIDEO 6 IMPROVING VARICOSE VEIN SURGERY WITH TRANSILLUMINATION 

A. Reichelt 

VIDEO 7 GREAT SAFENOUS VEIN ABLATION WITH LASER 1470 USING RADIAL EMISSION OPTICAL FIBER 

A. Reichelt 

VIDEO 8 ENDOVENOUSLASER:9 YEARS EXPERIENCE- LESSONS LEARNED 

A. Reichelt 

VIDEO 9 ENDOSCOPIC ASPECT OF ULTRASONIC GUIDANCE SCLEROTHERAPY WITH FOAM 

F. Vin 

VIDEO 10 ENDOVENOUS LASER ABLATION. DOES VEIN SIZE COMPROMISE SUCCESS? 

H. J. Poczwa 

41

42 

S C I E N T I F I C I N F O R M A T I O N 

AUDIO-VISUAL FACILITIES 

Speakers must go to the preview room VAN DONGEN, located on level - 2 of the Grimaldi 

Forum, in order to validate and download their presentation files according to the following 

schedule: 

• Morning Sessions: no later than the afternoon of the day before their communication. 

• Afternoon Sessions: no later than noon of the day of their communication. 

Please respect this schedule, otherwise, the performance of the received presentations is not 

guaranteed. 

We cannot accept presentations delivered in room directly (without previewing). 

Coffee breaks and midday are the busiest time in the preview room. So we recommend you to 

come to the preview early in the morning or during other presentations. 

Preview technical staff will guide and assist the speakers for checking and downloading their 

presentation files. 

A training computer will be available in order to help the speaker to use and be comfortable 

with the preview software and equipment in the conference room. 

The preview room will be open: 

• Sunday, August 30 th : from 15.00 to 19.30 

• From Monday, August 31 st to Thursday, September 3 rd : from 07.30 to 19.30 

both days included 

• On Friday, September 4 th : from 07.30 to 14.00 

ACCREDITATION 

The congress has been designated for 30 European CME credits (UEMS). Please come to the 

Registration desk for further information 

CERTIFICATE OF ATTENDANCE 

A Certificate of attendance is provided on request at the Registration desk. 

POSTERS EXHIBITION (Diaghilev area - Level -1) 

An area has been prepared for poster exhibition for viewing and discussing with the authors 

from 14.00 to 15.00, according the following schedule: 

• Monday, August 31st : posters DIA 1 to 16 

• Tuesday, September 1st : posters DIA 17 to 31 

• Wednesday, September 2nd : posters DIA 32 to 46 

• Thursday, September 3rd : posters DIA 47 to 61 

Authors must attend their poster display during the assigned sessions. 

Each poster session will be chaired by the poster General Chairmen and moderated by two 

Poster Discussants named by the congress’ Committee every day. 

A winner for the best poster will be elected on each session. 

Posters should be set up as soon as possible from Monday, August 31st on the board number 

assigned to your poster(s) and must remain displayed as long as possible. 

Posters should be removed on Friday afternoon from 17.00. All posters not removed will be 

destroyed. 

VIDEO THEATRE 

Accepted videos are running continously every day from 09.00 to 18.00 in Diaghilev Exhibition area.

VENOSAN ® is a registered trademark of SALZMANN AG, St.Gallen, Switzerland. 

Goodbye Tired Legs! 

Platinum Sponsor of the 

www.venosan.com

44 

E X H I B I T I O N P L A N

L I S T O F E X H I B I T O R S 

Companies Stands 

AD REM TECHNOLOGY 23 

AIM GROUP / DTC S3 

ANGIODYNAMICS UK LTD 14 

BAUERFEIND AG 27 + 18 

BIOLITEC AG 22 

CELON AG MEDICAL INSTRUMENTS 21 

CIZETA MEDICAL SPA 20 

COVIDIEN 9 

ESAOTE FRANCE 13 

ETS THUASNE 11 

EUFOTON SRL 16 

FILMAR SRL 24 

GEBRUEDER MARTIN GMBH & CO. KG 19 

GIBAUD 12 

GLORIAMED SRL 6 

GUTMANN MD GMBH S2 

HK SURGICAL INC. S1 

INNOTHERA 10 

KREUSSLER PHARMA 8 + 8BIS 

MEDI GMBH & CO. KG 26 

MINERVA MEDICA 17 

PIERRE FABRE 4 

RADIANTE - JOBST 3 

SERVIER INTERNATIONAL 5 

SIGVARIS 7 

STD PHARMACEUTICALS PRODUCTS LTD 26 

VENOSAN - SALZMANN GROUP 1 + 2 

VENOUS TIMES TABLE TOP 

VNUS MEDICAL TECHNOLOGIES GMBH 25 

WAGNER MEDICAL 15 

Village of Societies Stands 

UIP (Union Internationale de Phlébologie) 30 

ACP (American College of Phlebology) 31 

DGP (German Society of Phlebology) 32 

SFP (Société Française de Phlébologie) 33 

VASCULAR NEWS 34 

ROYAL SOCIETY OF MEDECINE PRESS 35 

Internet Point Stands 

VENOSAN - SALZMANN GROUP I1 

RADIANTE - JOBST I2 

MEDI GMBH & CO. KG I3 

BAUERFEIND AG I4 

SIGVARIS I5 

45

46 

ADMISSION 

G E N E R A L I N F O R M A T I O N 

The participant’s name badge is provided at the registration desk. All participants are requested 

to wear the badge throughout the Congress, including the Opening Ceremony and Welcome 

reception. 

CASH DISPENSER 

A cash machine is located on the entrance level next to the information desk of the Grimaldi 

Forum. 

COFFEE BREAKS 

During the Congress breaks, coffee, tea and refreshments are served free of charge to all 

registered participants wearing Congress badges. 

CONGRESS VENUE 

GRIMALDI FORUM: 10, Avenue Princesse Grace - Ph +377 99992000 

The Forum Grimaldi is the Convention Centre for the third millennium. 

Daringly built out over the sea, it is an architectural challenge consisting of a total area of over 

35.000 mq, split on various levels in order to enable different events to be held simultaneously 

and yet independently. 

During the congress you can discover the Grimaldi’s summer exhibition: "Moscou: Splendeurs 

des Romanov" situated on the 1st floor (Ravel space). As participant of the congress you will 

benefit from 25% reduction on the official price. Reduced price is € 7.50 instead of € 10.00. 

CURRENCY 

The currency in Monaco is the Euro. There are a number of currency exchanges which are 

open all day, including Sunday and bank holidays. 

Your hotel will provide you with details of your nearest currency exchange. 

ELECTRICITY 

The standard voltage in the Principality of Monaco is 220 V. Plugs are a two-pin style, continental. 

EXHIBITION (Located in Diaghilev floor, level -1) - (see plan page 44) 

In this industrial exhibition, diagnostic, pharmaceutical and other companies of related matters 

from all over the world, will be given the opportunity to put on display their products, services 

and new technical solutions. It provides a valuable forum to share pratical ideas and to discuss 

recent advances and future trends. 

The technical infrastructure of the Grimaldi Forum is of highest standard; its versatile infrastructure 

offers ample possibilities to build attractive stand constructions. 

VILLAGE OF SOCIETIES-INTERNET POINT - (see plan page 44) 

As part of the XVI World Meeting of the UIP, a Village of Societies and an Internet Point are 

located in the exhibition hall Diaghilev of the Grimaldi Forum, close to all other Congress 

activities such as scientific sessions, poster exhibition, registration and recreation areas etc.

LANGUAGE 


The official language of the Congress is English. 

Simultaneous translation is not provided for this congress. 

LIABILITY 

The Congress organizers shall only be liable for the delegates and their accompanying persons 

in case of gross negligence or willful misconduct in the deliverance of their obligations under 

the event agreement. The Congress organizers shall accept no responsibility or liability for 

events such as accidents, thefts or losses of property etc, as the delegates and accompanying 

persons are responsible for their own insurance. 

Registration does not include insurance. 

OPENING CEREMONY RECEPTION 

The Opening Ceremony will be held on Sunday, August 30th in room Prince Pierre followed 

by a cocktail in the Exhibition hall Diaghilev. 

TRANSFERS FROM NICE AIRPORT TO MONACO AND RETURN 

• By taxi: Prices for taxi transfers from Nice Airport to Monaco and return are approximately 

€ 80 (one-way day fare) or € 100 (one-way night fare). Taxis are available outside the Airport 

or can be ordered 24 hours a day by calling the following numbers: 

from Monaco: +377 93 15 01 01 

from Nice: +33 4 93 13 78 78 

• By public bus: Regular daily connections (Nice Airport - Monaco and/or return). Departures 

from Terminal 1 and 2 every hour, from 09.00 to 21.00. Duration 45 minutes - Price per way 

and per person: € 18 

• By helicopter: The Monaco Heliport, located right by the sea, offers numerous daily connections 

from Nice Airport - to Monaco and / or return with a duration of only 6 minutes flying. 

Upon arrival in Monaco, a shuttle will take you to your requested destination in the Principality 

of Monaco. 

- Contact details for Heli Air Monaco: 

e-mail: fabien@heliairmonaco.com - phone: +377 92 050 050 - fax: +377 92 050 036 - 

website: www.heliairmonaco.com. You may benefit from the following special Congress' 

rates if you indicate that you are attending the "XVI World Meeting of UIP". 

Nice - Monaco: € 100 per person (normal price € 120) 

Monaco - Nice: € 85 per person (normal price € 105) 

Return fare: € 175 per person (normal price € 210) 

HOW TO CIRCULATE IN MONTE CARLO 

(bus plan available in the Congress bag) 

Public bus transportation in Monaco is free for participants showing the Congress badge, from 

Saturday 29 th August to Saturday 5 th September (both days included). 

47

48 


TRAVELLING BY CAR 

Eastbound on A8 highway, please take the exit "Monaco/Cap d'Ail". Westbound, please take 

the exit "Roquebrune Cap Martin". 

Kindly note that 33 public car parks are available in the Principality of Monaco. If you park your 

car in the Grimaldi Forum car park, you may benefit from a special Congress' fare, provided that 

you get a special form from the Congress' Secretariat desk located in the main hall. 

TRAVELLING BY TRAIN 

The Grimaldi Forum is 15 minutes walking distance from the railway station and 5 minutes 

by public bus (line n° 4 - direction Larvotto). Use of Monaco Buses is free for delegates upon 

presentation of their official congress name tag. 

REGISTRATION FEES 

On-site registration (VAT 19,6% to be added): 

Physicians € 850 

Members of the DGP or of the SFP € 400 

Live-in nurses vascular technologists € 500 

Accompanying persons € 60 

Congress Gala dinner (1 st September) € 100 

SECRETARIAT DESK 

The Secretariat desk will be open during the following hours: 

Sunday, 30 th August 2009: 09.30 - 20.30 

Monday, 31 st August 2009: 07.30 - 18.30 

Tuesday, 1 st September 2009: 07.30 - 18.30 

Wednesday, 2 nd September 2009: 07.30 - 18.30 

Thursday, 3 rd September 2009: 07.30 - 18.30 

Friday, 4 th September 2009: 07.30 - 18.30

Monaco City Map 

50

Monaco 

de 

Publi Créations - Partner of AIM 

Presse de 

74, Bd d’Italie - 98000 Monte-Carlo - Monaco 

Centre 

Ph.: +377 97 97 3555 - Fax: +377 97 97 3550 

©Photos - 

E-mail: info@publicreations.com 

Website: www.publicreations.com p08126

p08126 UIP Final 2009_107.indd - AIM Group

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?